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Abstract
Migraine can be conceptualised as a disorder of sensory processing, manifest by such
symptoms as headache (pain), phonophobia and photophobia. Current models of
migraine pathophysiology incorporate a significant role for the brainstem. Vestibular
migraine (VM) is a subtype of the disorder in which significant brainstem dysfunction
has been documented. The condition is known to have a significant effect on mental
health. This study was designed to investigate disturbances in audiovestibular
brainstem function in vestibular migraine in a four part study:
1. Otoacoustic emission suppression by contralateral noise, a test of auditory efferent
pathway function, was measured in a group of 33 VM patients and compared with 31
healthy controls. Regression analysis showed a higher rate of abnormality amongst
the VM group (p=0.03).
2. Vestibular evoked myogenic potentials were recorded in a group of 30 VM patients
and compared with 35 healthy controls. Recordings showed a higher rate of abnormal
responses in the VM group than amongst controls (p=0.008).
3. The potential for vestibular stimuli to act as migraine triggers was investigated by
observing the effect of vestibular testing or a control condition on 148 individuals.
Vestibular stimulation was associated with a significant increase in the probability of
developing a migraine attack over the following 24 hour period (p=0.01).
4. Psychological symptoms of depression and anxiety were assessed using
questionnaires 39 patients with VM and compared with a control group of 44
patients with dizziness of other causes. Although the VM group had a significantly
higher load of symptoms of depression and anxiety, regression modelling showed
that this effect was largely accounted for by an excess of dizziness symptoms.
In conclusion, this study documents a number of audiovestibular sensory processing
abnormalities using a variety of techniques. Vestibular migraine has a significant
effect on psychological wellbeing, largely via the associated balance symptoms.
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Chapter 1: Introduction
1.1 Migraine and its pathophysiology
1.1.1 Definitions and disease burden
Migraine has been defined as an episodic headache disorder. Diagnosis of
migraine is made on clinical grounds, based largely on features of the
headache and associated symptoms, according to well-accepted international
criteria (Box 1)(International Headache Society Headache Classification
Committee 2004). Migraine is a highly prevalent disorder, with peak
incidence in the third decade. Its economic importance is illustrated by the
fact that it is responsible for average work absenteeism of 2.2 days per month
amongst employed sufferers (Osterhaus et al 1992). It is one of the most costly
neurological disorders in the European Community at more than €27 billion
per year (Berg and Stovner 2005).
Box 1 International Headache Society (2004) definition of migraine without
aura
All of criteria A-E must be fulfilled:
A. At least 5 attacks
B. Headache 4 – 72 hours duration
C. At least 2 of:
-Unilateral;
-Pulsating;
-Moderate/severe;
-Aggravation by routine physical activity
D. During headache at least one of
-nausea and/or vomiting or
-photophobia and phonophobia
E. Not attributed to another disorder
There is a considerable body of work related to the pathophysiology of
migraine with and without aura that has developed over the last two decades.
There still remains discussion as to whether neuronal, vascular or neuro-
vascular events are the initiating process, although any pathophysiological
theory must clearly account for a significant amount of neurovascular
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interaction. There are a number of different mechanisms proposed to have
causal pathophysiological roles.
1.1.2 Cortical spreading depression
Cortical spreading depression (CSD), analogous to the waves of Leão, has long
been thought to be a key process, especially in the one fifth of migraineurs
who experience aura symptoms before an attack. CSD consists of a wave of
depolarisation followed by a sustained depression in cortical surface potential.
The rate of spread of 2-6mm/min of CSD corresponds to the rate of spread of
a visual aura from central to peripheral vision. (Tfelt-Hansen 2010) CSD is
still a widely used animal and human model, but the precise mechanism of its
relationship to headache in humans remains unclear.
1.1.3 Genetic factors
Familial factors are thought to have a role in the development of migraine,
and genetic studies have contributed significantly to understanding of
migraine pathophysiology. Migraine is known to be 50% more common
among first degree relatives of sufferers than in matched controls. (Stewart et
al 1996) The risk is higher for those with more disabling symptoms than for
those with less disability, and higher for those with migraine with aura than
migraine without aura. Studies have also shown a higher rate of concordance
for monozygotic than dizygotic twins, and this effect is greater in females than
males. (Larsson et al 1995) Concordance in monozygotic twins is nevertheless
under 100%. Migraine is clearly genetically complex, with a non-Mendelian
mode of inheritance and mutations likely in multiple genetic loci. Mutations
are likely to effect changes in the threshold of susceptibility to migraine
attacks.
In familial hemiplegic migraine type 1, a rare autosomal dominant form of
migraine with a prolonged hemiplegic aura, various different pathogenic
mutations have been documented in CACNA1A, a P/Q voltage gated calcium
channel gene (see Table 1.I). (Ducros et al 1999) Other mutations in other
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genes have also been documented to cause related phenotypes (ATP1A2 in
FHM2 (Vanmolkot et al 2007) and SCN1A in FHM3 (Vahedi et al 2009)).
ATP1A2 codes for a Na/K ATPase, and mutations cause changes in the sodium
gradient across the cell membrane, with associated changes in synaptic
neurotransmitter levels. Similarly, mutations in SCN1A affect transmembrane
sodium flux.
There is a known association between FHM1 and basilar-type aura symptoms,
and between FHM1 and chronic progressive cerebellar ataxia in 50%
families.(International Headache Society Headache Classification Committee
2004)
Table 1.I Some single gene mutations have been identified as causal in
familial hemiplegic migraine
Gene Locus Gene
product
Migraine
subtype
Notes
CACNA1A 19p13 alpha 1 subunit
of voltage
gated calcium
channel
FHM type 1 at least 17
mutations
identified;
animal
models exist
ATP1A2 1q23 loss of function
of alpha2
NaKATPase
FHM type 2 at least 11
mutations
identified;
animal
models exist
SCN1A 2q24 alpha1 subunit
of voltage
gated Na
channel
FHM type 3 at least 2
mutations
identified
There are also a number of other genetic associations of migraine, including
MTHFR, ACE, ETA, and PGR, (Lee et al 2007; Rubino et al 2009; Tzourio et
al 2001) the latter being an association specific to migraine with vertigo. The
relative contribution of each is yet to be verified and quantified in different
populations.
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1.1.4 Evidence from channelopathies
Ion channel function is critical in the regulation of tissue excitability.
Channelopathies are a group of disorders that have been shown to be caused
by ion channel dysfunction (Catterall et al 2008). The group includes, for
example, hypo- and hyperkalaemic periodic paralysis and also the various
forms of episodic ataxia. Migraine shares several clinical features with known
channelopathies such as an episodic nature with characteristic triggers.
Additionally, many channelopathies exhibit migraine attacks as part of the
phenotype. Examples include episodic ataxia type II (Subramony et al 2003)
and the CADASIL syndrome (Pantoni et al 2010). These are part of a group of
single gene disorders, for which pathogenic genetic mutations are known, that
have a strong association with migraine. Recently a potassium channel genetic
mutation has been identified in the TRESK gene that co-segregated in a large
pedigree of individuals with migraine with aura (Lafreniere et al 2010).
1.1.5 Evidence from imaging
Models of migraine pathophysiology acknowledge that the brainstem plays a
key role in the genesis of the clinical features of migraine. Rostral brainstem
vascular malformation causing chronic migraine is reported (Goadsby 2002;
Lafreniere, Cader, Poulin, Andres-Enguix, Simoneau, Gupta, Boisvert,
Lafreniere, McLaughlan, Dube, Marcinkiewicz, Ramagopalan, Ansorge, Brais,
Sequeiros, Pereira-Monteiro, Griffiths, Tucker, Ebers, and Rouleau 2010).
Brainstem activation has been shown on PET scanning in typical spontaneous
and induced migraine without aura (Bahra et al 2001; Weiller et al 1995).
Furthermore, the activated brainstem areas encroach upon the location of the
vestibular nuclei as identified in previous lesion-based structural magnetic
resonance imaging (MRI) studies (Afridi et al 2005). Basilar-type migraine
strongly suggests a brainstem location in its symptomatology, hence the
nomenclature selected.
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1.1.6 Evidence from neurophysiology
Trigeminal nerve activation and subsequent changes in the cerebral
vasculature are widely acknowledged to be key steps in the pathology of an
attack, associated with a neurogenic inflammation with release of CGRP,
neurokinin A and 5-HT. These substances, when released, may cause irritation
of trigeminal nerve afferents (Iadecola 2002). The role of these neuropeptides
such as CGRP has also been explored (Goadsby et al 2009). CGRP is known to
be released during migraine attacks (Goadsby et al 1990), and CGRP receptor
antagonists are under investigation as migraine treatments (Goadsby 2008).
However, it is not only the nociceptive afferent pathways that mediate a
migraine attack. Disruption of the natural modulation of other sensory
pathways by central structures is also relevant (Goadsby, Charbit, Andreou,
Akerman, and Holland 2009). The resultant sensory sensitivity can take many
forms. Sensory stimuli may act as migraine triggers (Kelman 2007; Martin et
al 2006). Sensory stimuli can also exacerbate a migraine attack once initiated,
so that the sufferer will show behavioural responses in the form of avoidance
(Noseda et al 2010). In addition some individuals describe symptoms such as
ocular discomfort induced by light known as photo-oculodynia. It has been
shown that exacerbation of headache by light can occur in individuals
suffering with migraine who have preserved non-image forming visual
pathways but not in those with no optic nerves or eyes. In addition, the
presence of migraine photophobia was associated with the presence of
circadian light induced rhythms. The corresponding animal study in this
paper used a retrograde immunochemical tracing technique to show that light
exposure can modulate trigeminovascular thalamic neurons in the rat
(Noseda, Kainz, Jakubowski, Gooley, Saper, Digre, and Burstein 2010). It is
therefore suggested that thalamic processing of nociceptive and other inputs
could have a role in mediating migrainous symptoms. Further evidence for a
role of the thalamus comes from recent work identifying third-order thalamic
neurons as a possible site of action for CGRP receptor antagonists, as
administration of a CGRP receptor antagonist caused reduction in
spontaneous firing rate of cells in the ventroposteromedial nucleus of the
thalamus in rats (Summ et al 2010). It is not yet clear how such thalamic
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neurons might link to cortical pain processing areas, since higher projections
from the thalamus appear rather diffuse.
1.2. The relationships between migraine and the
audiovestibular system
1.2.1 Vertigo in basilar-type migraine
Vertigo is thought of as a characteristic symptom of disorder of the vestibular
system. It is globally acknowledged to be one possible symptom of the aura of
basilar-type migraine (Box 2) (International Headache Society Headache
Classification Committee 2004). However, this is but the first of many ways in
which migraine and the audiovestibular system interact. The relationship
between migraine and the sensory organs of hearing and balance is much
more complex and more controversial than this one instance suggests.
Box 2 International Headache Society (2004) definition of basilar-type
migraine
A. At least 2 attacks fulfilling criteria B–D
B. Aura consisting of at least two of the following fully reversible symptoms,
but no motor weakness:
-dysarthria
-vertigo
-tinnitus
-hypacusia
-diplopia
-visual symptoms simultaneously in both temporal and nasal fields of
both eyes
-ataxia
-decreased level of consciousness
-simultaneously bilateral paraesthesias
C. At least one of the following:
-at least one aura symptom develops gradually over ≥5 minutes and/or
different aura symptoms occur in succession over ≥5 minutes
-each aura symptom lasts ≥5 and ≤60 minutes
D. Headache fulfilling criteria for migraine without aura begins during the
aura or follows aura within 60 minutes
E. Not attributed to another disorder
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1.2.2 Childhood periodic syndromes
The IHS classification acknowledges vertigo additionally as the cardinal
symptom of benign paroxysmal vertigo of childhood. This condition is
referred to the in the IHS system as one of the childhood periodic syndromes
which are common migraine precursors. So, the second way in which
migraine and vertigo are related is that episodic vertigo can be a childhood
migraine precursor (Box 3).
Box 3. International Headache Society (2004) definition of benign
paroxysmal vertigo of childhood
This probably heterogeneous disorder is characterised by recurrent brief
episodic attacks of vertigo occurring without warning and resolving
spontaneously in otherwise healthy children.
Diagnostic criteria:
A. At least 5 attacks fulfilling criterion B
B. Multiple episodes of severe vertigo, occurring without warning and
resolving spontaneously after minutes to hours
C. Normal neurological examination, audiometry and vestibular functions
between attacks
D. Normal electroencephalogram
1.2.3. “Vestibular” migraine?
Thirdly, audiovestibular symptoms are now thought to arise directly from
migrainous processes. Although vestibular disorders and migraine are both
common in the general population, it has been shown that they co-incide
more frequently than would be expected by chance (Neuhauser et al 2001).
Kayan and Hood noted that migraine was more common in patients from a
specialist dizziness clinic than was tension headache (Kayan and Hood 1984).
Since then various authors have commented on the high prevalence of
vestibular symptoms in populations of migraineurs (Vukovic et al 2007), and
of migraine in groups of patients with vestibular symptoms (Savundra et al
1997). Estimates of the prevalence of dizziness, a less specific term than
vertigo, related to migraine are in the order of one third of those patients with
migraine (Bayazit et al 2001). There are numerous studies documenting
abnormalities of vestibular tests in migraineurs with vestibular symptoms
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including the results of caloric testing and eye movement recording with
rotation (Cass et al 1997; Cutrer and Baloh 1992; Dieterich and Brandt 1999;
Olsson 1991; Savundra, Carroll, Davies, and Luxon 1997). This group of
patients with vestibular symptoms related to migraine have been variously
referred to as having migraine-related vestibulopathy, (Cass, Furman,
Ankerstjerne, Balaban, Yetiser, and Aydogan 1997) vestibular migraine,
(Neuhauser and Lempert 2009) migraine related dizziness, (Johnson 1998)
migraine associated vertigo (Brantberg et al 2005) and migraine associated
dizziness (Cutrer and Baloh 1992). Research has, in the past, been hampered
by a lack of standardised terminology and internationally accepted diagnostic
criteria. In terms of clinical management, there are some studies, although
generally at lower levels of evidence (retrospective, uncontrolled data) that
show an improvement of vertigo symptoms in these patients when treated
with migraine prophylactics (Bikhazi et al 1997; Maione 2006; Reploeg and
Goebel 2002). Since, however, the mode of action of antimigraine drugs is
non-specific, with many of these drugs having numerous indications (e.g.
betablockers are used as anxiolytics), these data most be interpreted with
some caution.
In 2001 there was a seminal paper proposing clear clinical diagnostic criteria
for episodic vestibular symptoms as a migrainous phenomenon outside of the
context of basilar-type aura, and putting forward the term migrainous vertigo
(Neuhauser, Leopold, von Brevern, Arnold, and Lempert 2001). This group
however, has recently moved towards a different terminology, preferring the
term vestibular migraine (Neuhauser and Lempert 2009), without changing
the underlying definition. They argue that this term creates less confusion
with motion sickness associated dizziness or non –vestibular dizziness. It
might also be preferred since many of the vestibular symptoms which patients
with migraine encounter are not vertigo per se, including as they do head and
visual motion intolerance (Cass, Furman, Ankerstjerne, Balaban, Yetiser, and
Aydogan 1997). This group also showed that, although vestibular disease and
migraine are both common disorders, the co-incidence of migraine and
vertigo is three times higher than would be expected by a merely statistical
interaction of common disorders. Of course, this observation does not
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necessarily imply that migraine is causally responsible for the episodes of
vertigo that these individuals experience. It is commonly noted, however, that
episodes of vertigo in such patients may or may not be temporally related to
typical migraine headaches (Brantberg, Trees, and Baloh 2005; Neuhauser,
Leopold, von Brevern, Arnold, and Lempert 2001). Sensitivity to vestibular
(Seemungal et al 2006) and auditory stimuli in migrainous vertigo may be
analogous to the increased sensitivity to visual stimuli commonly seen in
migraine attacks. Motion sickness is long established as a common association
of migraine, especially in childhood (Barabas et al 1983; Grunfeld et al 1998).
The motion sickness induced by optokinetic stimulation in migraine patients
is thought to be related to activation of the vestibular nuclei (Drummond
2002). Alterations in the calibration or gain of vestibular reflexes could
account for the chronic imbalance seen in individuals with migrainous vertigo
as well as the episodic attacks (Crevits and Bosman 2005). The precise
pathological mechanism by which migraine might cause vertigo is
unelucidated.
1.2.4 Auditory symptoms in migraine
Phonophobia, arguably an auditory symptom, is of course part of the IHS
diagnostic schema for migraine, and is a characteristic symptom in
migraineurs. The word “phonophobia” is derived from the Greek roots
meaning “sound-fear”, and borrows its structure from behavioural psychology
terminology. Originally, then, it referred to the behavioural changes
associated with sound during a migraine attack, such as withdrawal from
noisy environments. In current usage, especially in the neurological literature,
however, it refers to the perception by the sufferer of an aversive effect of
sound. This could either manifest as a dislike of the sound per se, or it could
be manifest as exacerbation of headache pain by sound. This is the usage
adopted in this thesis. In the audiological literature, the term hyperacusis is
more commonly encountered. The Greek root for this word is “beyond-
hearing”, referring to heightened sensitivity to sound. It is used to refer to the
symptom of finding uncomfortable sound that would not normally be
perceived as such (Baguley 2003). Both phonophobia and hyperacusis should
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be distinguished from loudness recruitment. This is a phenomenon associated
with cochlear hearing loss, and is a consequence of a reduced dynamic range
for sound. Because of this reduced dynamic range, the growth of loudness
function is abnormal. Hypacusia (reduced hearing) and tinnitus can also occur
as basilar-type aura phenomena, although this is not common in clinical
practice.
1.2.5 Epidemiological associations of migraine with vestibular
disease
Fourthly, migraine is also statistically associated with a number of different
peripheral and central vestibular disorders including benign paroxysmal
positional vertigo (BPPV), episodic ataxia type II, and Menière’s disease. It
has been shown that BPPV is more common in migraineurs than would be
expected by chance (Celebisoy et al 2008b; Ishiyama et al 2000; Lempert et al
2000). As an explanation for this observation, it has been speculated that
inner ear damage due to vasospasm in migraineurs could predispose to BPPV
(Ishiyama, Jacobson, and Baloh 2000). In favour of this idea is the record of
case reports of infarction of the inner ear during migraine attacks, suggesting
that ischaemic compromise can occur in the inner ear during attacks (Lee et al
2003).
The association between migraine headache and Menière’s disease has long
been observed (Atkinson 1962). The difficulty in distinguishing between the
two disorders in some cases has caused comment, as both disorders are
associated with episodic vertigo, and are defined on clinical grounds rather
than objective investigations (Boyev 2005; Shepard 2006). In fact, this
dilemma makes ascertainment of auditory symptoms in migraine difficult,
since many authorities regard the mere presence of auditory symptoms as
evidence against migraine as a diagnosis, creating a circular argument.
Complex statistical algorithms which are not practical for use in everyday
clinical situations have been devised (Dimitri et al 2001). To add to the
diagnostic complexity, it seems that there is an association between the two
conditions, such that the lifetime prevalence of migraine is increased in
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patients with Menière’s disease (Ibekwe et al 2008; Radtke et al 2002). In one
study 28% of the patients with Menière’s disease described typical migrainous
headaches as associated always or sometimes with their Menière attacks.
Some authors have even gone as far as to suggest an overlapping pathology
between the two disorders (Baier and Dieterich 2009), although this is a
highly controversial notion. There is a high prevalence of migraine in the
population with Menière’s disease; and high prevalence of Menière’s disease
in migraineurs (Radtke, Lempert, Gresty, Brookes, Bronstein, and Neuhauser
2002; Rassekh and Harker 1992). Some cases have been reported to
experience migraine aura in the form of the Menière symptom complex
(Rassekh and Harker 1992). Again, as for BPPV, it has been suggested that
recurrent vasospasm caused by migraine attacks could result in the
development of endolymphatic hydrops (Lee et al 2002).
As well as BPPV and Menière’s disease, episodic ataxia type II has a strong
association with migraine. These disorders are characterized by attacks of
vertigo lasting hours. In episodic ataxia type II nystagmus is usually present
interictally. Many cases respond to treatment with acetazolamide (Baloh et al
1997).
1.2.6 Migraine as a prognostic factor in neuro-otology
Fifthly, migraine is known to be a poor prognostic factor in recovery from
acute vestibular syndromes (Best et al 2009c). This applies both to symptoms
of vestibular dysfunction and to associated anxiety and depression. The
reasons for this are not elucidated, although speculative pathophysiological
mechanisms include involvement of neurotransmitters, especially GABA
dependent systems, with a role in generation of migraine, and in psychological
symptoms and in mediating central vestibular connections, or a tendency to
increased intra-individual fluctuation of central neural excitability.
1.2.7 Vestibular stimuli as migraine triggers
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Sixthly, the role of vestibular stimuli as potential migraine triggers should be
explored. Migraine triggers are factors which elicit a single attack of migraine.
Studying migraine triggers contributes to understanding of the
pathophysiology of migraine, as well as contributing to practical aspects of
management such as trigger avoidance. Migraine triggers are known to range
from the common and well known such as lack of sleep, alcohol and menstrual
cycling (Kelman 2007), to the more esoteric such as Chinook winds (Cooke et
al 2000) and hair washing in Indian women (Ravishankar 2006). Other
sensory stimuli in different modalities including audition (noise)(Martin,
Reece, and Forsyth 2006), vision (glare) (Kelman 2007) and olfaction
(perfumes) (Kelman 2007) can also act as migraine triggers. The role of purely
vestibular stimuli is as yet unexplored.
1.3 Neuro-otological assessment of migraine and
vestibular migraine
1.3.1 Evidence from clinical studies
In the majority of patients with vestibular migraine assessed in the interictal
state, neuro-otological examination and investigations are normal (Cutrer and
Baloh 1992). Audiometry is also generally normal (Battista 2004) in patients
with migrainous vertigo, although sudden unilateral hearing loss is reported
in a series of case reports (Lee, Whitman, Lim, Yi, Cho, Ying, and Baloh
2003). The evidence that the hearing loss in these cases is due to migraine is
somewhat limited, due to the fact that it would be very difficult either to prove
or disprove in an individual case. One study of patients with migraine found
14% had latency prolongations on auditory brainstem response testing (Dash
et al 2008).
About a quarter of patients with migraine have peripheral vestibular
abnormalities interictally, and a smaller number show central abnormalities
(Furman et al 2003). For caloric testing and eye movement recording
techniques, the proportion of abnormalities is of the order of 20% for a canal
paresis and 10% for a directional preponderance (Celebisoy et al 2008a;
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Cutrer and Baloh 1992; Dieterich and Brandt 1999). These abnormalities can
also be noted in individuals with non-migrainous vestibular disease and in
migraineurs with no vestibular symptoms (Harno et al 2003). These
abnormalities cannot, therefore, be used to establish a diagnosis of vestibular
migraine. The proportion of patients with vestibular migraine who exhibit
objective signs of vestibular dysfunction rises when they are assessed during
an attack. In a study of ictal eye movements in vestibular migraine, 14/20
showed pathological nystagmus of various types including spontaneous
vestibular or central nystagmus, positional nystagmus and various
combinations of these (von Brevern et al 2005). These abnormalities suggest
significant brainstem dysfunction in this group of patients.
Various electrophysiological techniques have confirmed interictal
abnormalities in different groups of migraineurs consisting of lack of
habituation of evoked potentials, including cortical auditory evoked
potentials. A small study of patients with migraine and vestibular symptoms
showed a larger modulation component of the otolith-ocular reflex than
normal controls, and increased sway on posturography (Furman et al 2005b).
Neuro-otological investigation of vestibular migraine to date has failed to
show any single abnormality which occurs with sufficient frequency to be of
diagnostic utility as a biomarker. The overall picture from the literature shows
a mixture of central and peripheral findings occurring in a minority of patients
interictally, increasing ictally, with no single abnormality of either structure or
function being implicated.
1.3.2 The neurophysiological interface between migraine and
vestibular disease
Current explanations of the pathophysiological mechanism of vestibular
migraine thus remain largely based on what is known about migraine in
general and plausible ways in which this could relate to peripheral or central
vestibular structures.
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There are also neuro-pharmacological interactions between the migraine and
the vestibular system. There are animal models which have been developed,
involving plasma extravasation in the inner ear after 5-HT administration
(Koo and Balaban 2006).
This model showed parallel plasma extravasation in the vestibular periphery
and meninges in a murine model of neurogenic migraine. Sites of action of
triptans, well established as anti-migraine drugs are present in both the
vestibular and trigeminal ganglia and the vestibular and trigeminal nuclei.
Areas encroaching on the vestibular nuclear areas have been seen to be
activated has during PET scanning of migraine attacks (Afridi, Giffin, Kaube,
Friston, Ward, Frackowiak, and Goadsby 2005). Both spontaneous and
glyceryl trinitrate induced (Afridi, Giffin, Kaube, Friston, Ward, Frackowiak,
and Goadsby 2005; Bahra, Matharu, Buchel, Frackowiak, and Goadsby 2001)
migraine headaches are accompanied by increased cerebral blood flow in a
region of the dorsal and dorsolateral pons that appears to include portions of
the vestibular nuclei, medial parabrachial nucleus, locus coeruleus and raphe
nuclei (Moore and Bloom 1979). A large proportion of vestibular
ganglia are immunopositive for receptor targets of triptans, such as 5-HT1B,
5HT1D and 5-HT1F (Ahn and Balaban 2010). It is known that there are
trigeminal nerve afferent endings within the inner ear which could
theoretically be activated in an attack of vestibular migraine (Vass et al
1998a). In addition, the trigeminal ganglion provides sensory innervation to
the vertebrobasilar, anterior inferior cerebellar and labyrinthine arteries,
providing further neuroanatomical connection between the two systems (Vass
et al 2004).
Cortical spreading depression could be relevant in some cases, especially in
the minority whose vertigo conforms to the known pattern of aura. It has been
noted that trigeminal nerve activation by painful stimulation of the forehead
produces or modifies nystagmus in migraineurs but not in healthy controls
(Marano et al 2005). This observation shows the potential for a
pathophysiological link between vestibular symptoms and headache. In
addition, as outlined above, there is evidence of significant brainstem
dysfunction in the acute phase of attacks seen in eye movement recordings of
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nystagmus. There is therefore a need to investigate pathophysiological
sensory processing in individuals with migraine and vestibular disease, and
this could reasonably focus on audiovestibular brainstem function. Two
potentially useful techniques for executing such an assessment are the
recording of vestibular evoked myogenic potentials, and the suppression of
otoacoustic emissions by contralateral noise, since both techniques assess
pathways travelling through the brainstem.
1.4 Effect of vestibular migraine on individual sufferers.
Vestibular migraine is common, with an estimated lifetime prevalence of
0.98% ascertained by a prospective population based telephone interview
study in Germany (Neuhauser et al 2006). Two thirds of those who had VM
according to Neuhauser’s original criteria (Neuhauser, Leopold, von Brevern,
Arnold, and Lempert 2001) had sought medical help, but only one fifth of
these had been correctly diagnosed. 37% had seen more than one specialist in
the course of the condition. The data from this study also suggest a significant
impact of symptoms on quality of life, although the confidence intervals in the
patient group are wide due to the small numbers of individuals who had
suffered an attack in the study window (previous four weeks). Notably,
patients with vestibular migraine scored worst on the mental health and
emotional wellbeing domains. This is in keeping with literature noting the
effect of both migraine and vestibular disease on mental health (discussed in
more detail below). It is known that vestibular migraine has a negative effect
on mental health, but it is not known to what extent the different components
of the condition (migraine symptoms and vestibular symptoms) contribute to
this situation.
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Chapter 2. Methodology
2.1 Research hypotheses
2.1.1 Major hypothesis
 Migraine in general, and vestibular migraine (VM) in particular, are
characterised by excessive and inappropriate responses to
audiovestibular sensory stimuli.
2.1.2 Subsidiary hypotheses
 The effects of altered sensory modulation in individuals with VM can be
demonstrated using the following techniques:
o Assessment of objective audiovestibular function using:
 vestibular evoked myogenic potentials; and
 otoacoustic emission recordings including suppression by
contralateral noise
o Clinical responses to vestibular stimuli i.e. a “trigger” effect of
sensory stimulation
 The recognised psychological effects of vestibular migraine are due to a
synergistic effect between the migraine and vestibular symptoms, so
that those with vestibular migraine experience greater psychological
symptom load than non-migrainous dizzy controls.
2.2 Setting
The study was divided into four subsections, and more detailed descriptions of
participants and methods are given in the chapters describing these
subsections below. Chapter 3 of this thesis describes the subsection
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concerning otoacoustic emissions and suppression, chapter 4 describes the
use of vestibular evoked myogenic potentials, chapter 5 the investigation of
vestibular stimuli as a potential migraine trigger and chapter 6 describes the
psychological symptoms associated with vestibular migraine. This
introductory section describes general principles which apply to the study as a
whole.
Patients attending the Neuro-otology and Neurology clinics in a specialist
neurological hospital between June 2007 and July 2009 were approached to
participate prospectively. The study was conducted with the approval of an
institutional ethical standards committee on human experimentation (UCLH
Alpha Committee Ref 07/Q0502/30). All participants gave written informed
consent to be in the study.
2.3 Definitions
Migraine was defined according to the criteria of the ICHD-II.(International
Headache Society Headache Classification Committee 2004) Migrainous
vertigo (vestibular migraine) was defined according to the criteria of
Neuhauser et al (Neuhauser, Leopold, von Brevern, Arnold, and Lempert
2001) for “definite” migrainous vertigo, which incorporate the requirement for
a diagnosis of migraine according to IHS (2004) criteria (See Box 4).
Diagnosis was confirmed using a semi-structured interview / questionnaire
(see appendix 1).
2.4 Participants
Participants were excluded if they had any neurological, medical or
orthopaedic problem that could interfere with test procedures. All subjects
had normal neurological examination with no fixed signs of brainstem
dysfunction.
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Box 4: Diagnosis of definite migrainous vertigo (vestibular migraine)
The following criteria must be met
-Episodic vestibular symptoms of at least moderate severity (rotational
vertigo, other illusory self or object motion, positional vertigo, head motion
intolerance, i.e. sensation of imbalance or illusory self or object motion that is
provoked by head motion)
-Migraine according to the ICHD-II criteria
-At least one of the following migrainous symptoms during at least two
vertiginous attacks: migrainous headache; photophobia; phonophobia; visual
or other auras
-Other causes ruled out by appropriate investigations
Vestibular symptoms were defined as “mild” if they did not interfere with
daily activities, “moderate” if they interfered with but did not impede daily
activities, and “severe” if patients could not continue daily activities.
41 patients participated in the otoacoustic emission study (chapter 3) and/or
the vestibular evoked myogenic potential study (chapter 4). Some patients
participated in more than one part of the study (33 participated in both
otoacoustic emissions and vestibular evoked myogenic potentials; 6 in only
the otoacoustic emission study and 2 in only the vestibular evoked myogenic
potential study). All these patients also completed the questionnaires for the
psychopathology study (chapter 6). The 123 patients described in chapter 5
comprised an entirely separate population.
Controls were recruited from hospital staff, colleagues and friends. They were
required to be well, with no known otological or vestibular problems. All
controls were asked about the experience of headache, and excluded if they
had ever suffered spontaneous headaches with migrainous features (severe
pain or headache associated with nausea or photophobia/phonophobia).
2.5 Sample size estimation
Sample size was calculated prior to data collection to estimate numbers
required. It had been previously reported (Murofushi et al 2001) that in
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vestibular evoked myogenic potentials with a similar protocol to that used in
this thesis, mean p13 latency was 17.3 ms with SD 2.6 ms. In normal controls
the equivalent figures were 11.8 ms and 0.86 ms, with the upper limit of the
normal range estimated as 13.5 ms. To detect a difference in latencies of 2 ms
or more, power required 95% for significance level 0.05 with F = 12.99 (from
table). Using n > 2Fσ2/d2 requires approximately 44 subjects. Hence it was
decided to aim for n=40 subjects in the electrophysiology studies.
2.6 Audiovestibular tests
Participants underwent baseline audiovestibular testing according to the
following protocols. Tympanometry was carried out to ensure normal middle
ear function (GSI 33 Middle Ear analyser). Normal results were a type A trace
according to Jerger’s classification, with compliance between 0.3 and 1.4ml
and pressure between -100 and +100 daPa (Jerger J 1970). Pure tone
audiometry was carried out according to British Society of Audiology standard
procedures (British Society of Audiology 1981) on a GSI 61 Clinical
Audiometer instrument in sound treated booths.
Auditory brainstem response (ABR) tests and/or stapedius reflex thresholds
were measured on all patients. ABR was carried out with a Nicolet EP4 system
using a 90 dB nHL click at 11.1/s. Stapedius reflex thresholds were measured
on the GSI 33 Middle Ear Analyser at 500 Hz and 1,2, and 4 kHz. All patients
who were participants in the electrophysiology studies (chapters 3 and 4) had
normal ABR (normal waveforms, latencies of I, III and V, and interaural wave
V symmetry according to departmental norms) and/or stapedius reflex
thresholds (between 80 and 100 dB SPL, difference <10 dB on adjacent
frequencies (Katz 1994)).
For vestibular testing, horizontal direct current electro-oculography was
carried out according to a standard protocol: gaze testing (+/- 30° searching
for nystagmus in the light and darkness), sinusoidal rotation, vestibulo-ocular
reflex suppression, impulsive rotation, optokinetic stimulation and smooth
pursuit. Sinusoidal rotation was carried out in the dark using a motorised
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chair driven at a frequency of 0.2 Hz, peak velocity of +/- 30°/s for a duration
of approximately eight cycles. Ability to suppress the vestibulo-ocular was
then tested by repeating the sinusoidal stimuli and asking the patient to
visually fixate on a target which moves with them (i.e. stationary with respect
to the patient), for approximately four cycles. Impulsive rotation comprised
velocity steps at +/- 60 °/s until nystagmus subsides (approximately 45
seconds, maximum of 100 seconds; approximate acceleration/deceleration (-
140 °/s2). In full field optokinetic testing the subject was stationary whilst the
surrounding striped curtain revolved at a speed of 40 °/s, alternating direction
every 5-10s for a total of approximately 30s. For smooth pursuit subjects were
required to track a laser-projected target moving in a sinusoidal fashion at 0.2,
0.3 and 0.4 Hz. All patients in the vestibular test group underwent bithermal
water caloric testing using a 40 second irrigation in each ear at 44°C and 30°C
according to the Fitzgerald-Hallpike technique or videonystagmography.
Canal paresis was calculated using nystagmus duration according to Jongkees’
formula: [(Right 30°C + Right 44°C) - (Left 44°C + left 30°C)]/(Right 30°C +
Left 44°C + Right 44°C + Left 30°C). Likewise, directional preponderance
was calculated as [(Right 30°C + Left 44°C) - (Right 44°C + left 30°C)]/(Right
30°C + Left 44°C + Right 44°C + Left 30°C). For canal paresis, departmental
norms for used (8% for Fitzgerald-Hallpike or 20% for VNG). For directional
preponderance, 12% for Fitzgerald-Hallpike or 20% for VNG are the normal
values.
2.7 Overview of Methods
More detailed descriptions of the methods are given in each chapter. A brief
overview is given here for orientation to the study as a whole.
2.7.1 Otoacoustic emission suppression study
Patients with vestibular migraine underwent otoacoustic emission
suppression testing (for detailed description of technique and protocols see
chapter 3). They were compared with healthy non-migrainous controls in a
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case-control study design. The principal outcome of interest was the degree of
otoacoustic emission suppression.
2.7.2. Vestibular evoked myogenic potential study
Patients with vestibular migraine underwent cervical vestibular evoked
myogenic potential testing (for detailed description of technique and protocols
see chapter 4). They were compared with healthy non-migrainous controls in
a case-control study design. The principal outcomes of interest were the
amplitude, latency and threshold of the vestibular evoked myogenic potential
response.
2.7.3. Vestibular stimuli as migraine triggers
In this study, patients attending the neurology or neuro-otology clinic were
classified as having migraine or not according to standard IHS criteria. They
were allocated, prospectively, according to the treating physician’s decision, to
having a vestibular test protocol (Test group) or not (Control group). All
participants were contacted after 24 hours to determine the presence or
absence of migrainous symptoms in the 24 hours immediately after testing.
The test and control groups were compared to establish whether there was a
difference in the frequency of migraine headaches after testing (or hospital
visit with no tests). More detailed description of the methods is given in
chapter 5.
2.7.4 Psychopathology in vestibular migraine
The patients participating in the otoacoustic emission and vestibular evoked
myogenic potential parts of the study also completed questionnaires to
determine psychological symptomatology including the Beck Anxiety and
Depression Inventories, and the Vertigo Symptom Scales (in Appendices 4, 5
and 6). A group of patients who were consulting for symptoms of dizziness but
did not have migraine acted as controls. The scores were analysed using
regression modelling to evaluate the factors which had an effect on
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determining levels of anxiety and depression symptom load in the two groups.
More details are given in Chapter 6.
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Chapter 3. Otoacoustic emission suppression by
contralateral noise in the assessment of vestibular
migraine
3.1 Principles and context.
Otoacoustic emission (OAE) suppression testing is another technique that can
be used to assess audiovestibular sensory processing (Murdin and Davies
2008). The technique was developed by Collet (Veuillet et al 1996), Kemp
(Kemp 1978) and Berlin (Berlin et al 1993), among others. It is based on the
principle that when otoacoustic emissions are recorded with and without the
presence of noise, recording in the noise condition shows reduced amplitude
in comparison with the quiet condition (Murdin and Davies 2008). The
afferent arm of the reflex assessed by OAE suppression travels in the auditory
nerve, and the efferent arm along the inferior vestibular nerve. The efferent
auditory pathway is postulated to have a role in modifying the gain of cochlear
responses, perhaps to protect from excessive noise or aid in selective
attention. It could thus be particularly suitable to assess patients with
vestibular migraine in whom phonophobia is a common symptom. Indeed,
phonophobia is listed as one of the key diagnostic symptoms in the current
International Headache Society (2004) definition of migraine (see Chapter 1
Box 1). (International Headache Society Headache Classification Committee
2004)
3.2. Anatomical structures and pathways
There are two olivofugal pathways to the auditory efferent system. The first is
the medial olivocochlear bundle (MOC), running from the superior olivary
complex to synapse on the outer hair cells of the cochlea (Figure 2.1). Fibres in
the MOC, which are mostly large and myelinated, travel predominantly along
the contralateral inferior vestibular nerve, having crossed over the midline
once in the trapezoid body (de Venecia et al 2005). The second olivofugal path
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is the lateral olivocochlear (LOC) bundle, consisting mainly of smaller
unmyelinated fibres, and it is predominantly ipsilateral. It originates in the
superior olivary complex and crossing over once in the trapezoid body and
once in the crossed olivocochlear bundle at the floor of the fourth ventricle.
MOC neurones synapse directly onto outer hair cells, whereas LOC neurones
synapse onto the afferent auditory nerve fibres (Guinan, Jr. 2006). Both
pathways are subject to “top down” modulation by the auditory cortex (Xiao
and Suga 2002).
Outer hair cell activity modulating cochlear amplifier gain is thought to be the
cause of otoacoustic emissions. They are by-products of outer hair cell activity,
a consequence of their contractile characteristics (owing to the presence of
myosin filaments). Outer hair cells contract in response to sound waves and to
passive vibrations of the basilar membrane, with both anterograde and
retrograde transmission. The retrograde transmission is measured as
otoacoustic emissions. Since MOC neurones synapse directly onto the outer
hair cells, it is not surprising that changes in MOC activity influence OAE
properties. Noise stimulation activates the efferent pathway and suppresses
the OAE amplitude, and additionally causes a phase shift of the OAE response
(Ryan et al 1991). This suppressive effect has been demonstrated in
spontaneous (Mott et al 1989), transient evoked (Collet et al 1992), stimulus
frequency (Guinan, Jr. 2006) and distortion product OAEs. (Wagner et al
2005).
As the auditory efferent system travels along the inferior vestibular nerve,
vestibular nerve section presumably disrupts its normal function. OAE
suppression is indeed lost in subjects with vestibular deafferentation due to
vestibular nerve section (Williams et al 1993). OAE suppression has been
observed in patients with Bell’s palsy and other conditions with absent middle
ear reflexes, suggesting the phenomenon is not mediated via the middle ear
reflexes (Giraud et al 1995). The phenomenon is highly frequency specific,
which is not a feature of middle ear reflexes, and was shown to be robustly
observable at intensities below the acoustic reflex threshold (Veuillet et al
1991). In addition, animal studies have shown+- that crossed olivocochlear
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bundle stimulation suppresses OAEs even when middle ear muscles have been
severed (Mountain 1980).
Figure 3.1. Lateral olivocochlear pathway (LOC) is shown as dashed lines.
Medial olivocochlear pathway (MOC) is shown as bold lines. Lateral
olivocochlear axons innervate the dendrites of radial afferent fibres under the
inner hair cells. Developed from (Ceranic 2007).
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There are many hypotheses as to the physiological role of the MOC system. It
has been suggested to shift the dynamic range of hearing to enhance signal
detection and frequency selectivity (May et al 2004), to protect from excessive
noise (Brown et al 1998; Maison and Liberman 2000) and aid in selective
attention (Hill et al 1997).
3.3. Principles of OAE suppression technique
In essence, the OAE is recorded using an evoking click or tone both with and
without suppressive noise, and the difference in amplitude of the two
responses is calculated (TEOAEq – TEOAEn, Figure 3.2).
Parameters relating to both evocation of the OAE and to the suppressive noise
can affect results.
Figure 3. 2 The principle of recording OAE suppression by contralateral
noise. The value of suppression is equal to the difference between TEOAEq
and TEOAEn.
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3.3.1 OAE evoking stimulus parameters
Suppression effects are larger as stimulus level decreases, because cochlear
amplifier gain is largest at low evoking stimulus presentation levels (Moulin et
al 1993). A low intensity stimulus also avoids the problem of confounding
middle ear muscle contraction. However, the stimulus must be big enough to
produce a recordable OAE, detectable above the noise floor and for the
suppressive effect to be measurable. For transient click evoked OAE
suppression in normal hearing individuals, a click stimulus of around 60 dB
SPL may be suitable. The uniform click is often selected in favour of the usual
reverse-polarity click because the evoked responses will therefore contain a
larger proportion of the cochlear responses. Since the outcome of interest is
an intra-individual difference, the need for a reverse polarity click to
distinguish artefact from response is lessened.
3.3.2. Suppressive noise stimulus parameters
The MOC can be activated by low (just audible) levels of noise, and the
suppressive effect increases with higher intensities (Collet et al 1990; Ryan,
Kemp, and Hinchcliffe 1991). As is the case for the OAE evoking stimulus, the
noise stimulus must use a sound intensity which is too small to elicit middle
ear muscle contraction, i.e. less than around 75 dB SPL for broadband noise.
Many groups have found that white or broadband noise at 30 to 40 dB SL is
adequate (Collet, Veuillet, Bene, and Morgon 1992; De Ceulaer et al 2001;
Hood et al 2003). Testing can be done using ipsi-, contra- or bilateral noise,
and most centres have used contralateral noise (Attias et al 2005; Ceranic et al
1998; Collet, Veuillet, Bene, and Morgon 1992; Norman and Thornton 1993).
It is reported that the suppressive effect is greatest using binaural noise, with
a lesser effect from ipsilateral noise and, in fact, contralateral noise results in
the weakest suppression (Hurley et al 2002). However, using ipsilateral or
binaural noise creates problems in distinguishing signal from noise in the
responses, and thus requires more complex analysis or the use of forward
masking techniques. Hence, for simplicity, the use of contralateral noise is
often preferred.
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3.3.3. Which type of OAE?
For greatest frequency specificity, distortion product OAEs may be preferred.
The main disadvantage of using distortion product OAEs is that the effect of
noise is not always suppressive in normal subjects (Riga et al 2007). The
magnitude of the effect is also small. These two factors mean it is difficult to
interpret single measurements. Stimulus frequency OAEs are technically more
difficult to record, but are perhaps more easily interpretable (Guinan, Jr.
2006). Most clinical work has been done using transient evoked OAEs
(TEOAEs).
3.3.4. Interpretation of results
Significant inter- and intra-individual variability of contralateral suppression
of TEOAEs has been reported in 6 healthy normals aged 22 – 67 (Graham and
Hazell 1994). Giraud et al (Giraud, Collet, Chery-Croze, Magnan, and Chays
1995) confirmed the presence of TEOAE suppression in 20 normal subjects,
but in some the suppression was weak, and in several cases very asymmetric.
This study found no difference between left and right ears and no testing
order effect when results were averaged across all individuals. Wagner
(Wagner, Heppelmann, Kuehn, Tisch, Vonthein, and Zenner 2005) however
found good test-rest reliability in young healthy military service subjects using
distortion product OAEs. It seems likely that factors such as repeatability vary
considerably depending on the protocol selected, and possibly also on subject
factors such as age.
Morand-Villeneuve and colleagues in Lyon reported an asymmetrical effect of
benzodiazepines on OAE suppression, with oxazepam having a larger impact
on the right than the left ear (Morand-Villeneuve et al 2005). This group has
also noted asymmetries in suppression which co-vary with gender and
handedness in people under 34 (Khalfa et al 1998). Values of suppression are
greater in the right ear in right handed people, but this asymmetry effect is not
seen in left handed people, in whom both ears show values similar to the right
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ear of right handed people.
Using contralateral noise and TEOAEs, a suppression level below 1.0 dB SPL
is often taken as abnormal. This figure gave a false negative rate of about 17%
in extrinsic brainstem lesions (n=18) and 0% in intrinsic brainstem lesions
(n=11) (Prasher et al 1994).
It has been reported that the suppressive effect is smaller in older subjects
than in a younger group (Castor et al 1994). Conflicting reports exist however,
showing no effect of age, using a broadly similar protocol (Quaranta et al
2001). A decrease in suppression of distortion product OAEs in middle and
older aged groups is reported when compared to younger subjects (Kim et al
2002). It seems likely that there is a gradual fall-off in efferent system
function with increasing age. This may be compared with the effect of age on
TEOAE amplitude.
At the other end of the age scale, the phenomenon is absent in many
premature newborns up to around 34 weeks gestation and becomes
increasingly apparent with postnatal maturity (Chabert et al 2006). However,
as the afferent arm of the reflex was not assessed independently in this report,
it is not possible to tell from these data whether this delay is related to the
known maturational effect in the afferent arm, or can be localised to the
efferent pathway.
Middle and outer ear factors can have a big effect on recording of OAEs, and
suppressive effects may be masked if recording conditions are not optimal. It
is considered prudent where possible to make recordings where
tympanometry is normal and the external ear is clear of wax and debris;
otherwise false positive results may be obtained.
The suppressive effect is observed during sleep but in almost half of cases no
suppression is seen at the onset of sleep. Some authors recommend that
subjects read during testing to prevent any possible reduction in effect (De
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Ceulaer, Yperman, Daemers, Van Driessche, Somers, Offeciers, and Govaerts
2001).
Direct electrical stimulation of MOC fibres is used in animal studies, and MOC
effects seem to be larger in these experiments. When OAE suppression is
compared with cochlear neural responses as a function of MOC stimulation,
cochlear neural responses always show a greater response. In other words, the
use of OAE techniques to assess efferent system activity is subject to some
idiosyncrasy due to the properties of TEOAEs (Guinan, Jr. 2006). Some
patients do not lose suppression completely after vestibular neurotomy
(Giraud, Collet, Chery-Croze, Magnan, and Chays 1995), suggesting either that
some efferent fibres do not travel in the vestibular nerve, or that middle ear
reflexes have a role to play in these circumstances
TEOAE recording, and so also suppression testing, is an imperfect assay of
cochlear activity and efferent pathway function. Only a fraction of the acoustic
energy emitted by the cochlea can be recorded in clinical scenarios, and the
use of suppression testing to assay efferent function is clearly somewhat
indirect.
3.4 Clinical applications
3.4.1 Neurological disorders: Cerebello-pontine angle tumours.
Four cases of vestibular schwannoma (acoustic neuroma) are reported in
which the amplitude of distortion product OAEs was larger in the affected
than the unaffected side, suggesting disinhibition and therefore possible
involvement of the MOC system (Gouveris and Mann 2004). Other work is
broadly consistent with this hypothesis, although these cases were selected
retrospectively from pool of 106 patients, suggesting the effect is not a
common one. One study compared TEOAE suppression by contralateral noise
in 17 patients with unilateral cerebello-pontine angle tumours with normal
controls (Ferguson et al 2001). There was no difference between ears in the
patient group. However, there was a difference between control ears and
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patient ears (with or without tumour), with normal control subjects showing
greater suppressive effects. This suggests that there is impairment of the
afferent and efferent pathways on both sides occurring within the tumour
group. This may be explained by the diversity of lesion size and precise
location.
There are also reports of paradoxical effects of noise on OAE amplitude in
patients with acoustic neuroma; that is, an increase in amplitude with noise
stimulation (Quaranta et al 2000). The authors speculate that the pathology
could impact adaptation occurring at the level of efferent nerve fibre
transmitter release, enhancing outer hair cell motion response instead of
suppressing it.
In a very useful and clear study of the practical use of OAE suppression as a
diagnostic test, OAE suppression was studied in patients with a variety of
intrinsic and extrinsic brain lesions (Prasher, Ryan, and Luxon 1994). In those
with cerebello-pontine angle tumours, the affected ear showed reduced
suppression, and suppression was reduced bilaterally in those with intrinsic
brainstem lesions. Similarly, it has been reported that OAE suppression can
be affected by cholesterol cysts of the midline petrous apex which are known
to affect the efferent pathway (Hurley, Hurley, and Berlin 2002).
3.4.2 Neurological disorders: Multiple sclerosis.
In a comprehensive evaluation of 30 patients with multiple sclerosis, TEOAE
suppression was significantly reduced when compared with normal controls
(Coelho et al 2007). The results of this study illustrate the fact that
suppression testing is a useful addition to the auditory test battery when
evaluating such patients. It is worth noting however that most of the ears with
abnormal suppression testing also had abnormal auditory brainstem
responses, so that the lesion cannot be confidently localised to the efferent
pathway.
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3.4.3 Neurological disorders: Myasthenia gravis.
In an elegant pharmacological study, suppression of disortion product OAEs
in patients with myasthenia gravis was examined before and after
acetylcholinesterase inhibitor administration (Di Girolamo et al 2001). In the
pre-administration condition there was no significant suppression. After
administration however, contralateral noise produced a significant decrease of
disortion product OAE amplitudes for middle frequencies (f2 between 1306
and 2600 Hz). The authors suggested that the drug-induced increase in
acetylcholine availability could facilitate outer hair cell function, and that
contralateral suppression of distortion product OAEs may be useful in
monitoring the effectiveness of treatment. These results were independently
confirmed by another group, who reported that patients with myasthenia
gravis have reduced disortion product OAE suppression, but that such an
effect was not seen with TEOAEs (Hamed et al 2006).
3.4.4 Audiological disorders: Tinnitus and hyperacusis
Patients with tinnitus after head injury have been shown to have both larger
TEOAE amplitudes and less suppression than either normal subjects or
patients with head injury but no tinnitus (Attias, Zwecker-Lazar, Nageris,
Keren, and Groswasser 2005; Ceranic, Prasher, Raglan, and Luxon 1998).
Patients with acute tinnitus also had less suppression of disortion product
OAEs than normal controls (Riga, Papadas, Werner, and Dalchow 2007)
although no difference in suppression was shown in this study between
symptomatic and asymptomatic ears. It has been reported that OAE
suppression can be deficient in some cases of hyperacusis (Collet, Veuillet,
Bene, and Morgon 1992). A review of studies of patients who have undergone
vestibular nerve section (and therefore presumed de-efferentation) showed
that the majority experience no increase in complaints of tinnitus (Baguley et
al 2002). Nevertheless, in individual studies up to 60% of this population do
experience worsening of symptoms, and it is possible that efferent system
dysfunction is relevant to an unidentified subgroup. Effects of vestibular nerve
section on symptoms of hyperacusis are less well documented, although one
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study reported no effect on various psychoacoustic tests of loudness
adaptation in a series of 15 patients (Scharf et al 1997).
3.4.5 Audiological disorders: Hazardous noise exposure
Section of the olivocochlear bundle in chinchillas increases susceptibility to
acoustic trauma (Zheng et al 1997). This effect has also been demonstrated in
guinea pigs (Maison and Liberman 2000). These results have been taken to
suggest that the olivocochlear system may have a role, up to a point, in
protecting from noise exposure. OAE suppression is indeed reduced in human
subjects exposed to noise (Desai et al 1999), and has even been mooted as a
method of early identification for at-risk workers (Sliwinska-Kowalska and
Kotylo 2002), although there is currently little evidence that suppression
testing would have any advantage over other methods such as TEOAE
measurement.
OAE suppression has been examined in military personnel after impulse noise
exposure (Veuillet et al 2001). Significant correlations were obtained between
audiometric threshold improvement and contralateral TEOAE suppression,
with better recovery in subjects with greater MOC suppressive action. The
authors suggested that the MOC system could be an underlying mechanism in
post-traumatic auditory threshold recovery. However, a similar study which
attempted to correlate temporary threshold shift in healthy young men with
degree of contralateral suppression of DPOAEs showed no such effect
(Wagner, Heppelmann, Kuehn, Tisch, Vonthein, and Zenner 2005). The
relevance of this latter observation may be questioned since temporary
threshold shift is known not to correlate with permanent threshold shift.
Dysfunction of the MOC may be a factor in susceptibility to the development
of tinnitus or hyperacusis, especially in the context of noise induced hearing
loss. Indeed, patients with noise-induced tinnitus have less suppression than
normal controls or those with tinnitus due to other causes (Attias, Zwecker-
Lazar, Nageris, Keren, and Groswasser 2005).
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Classical musicians have been shown to have a greater degree of OAE
suppression than non-musicians (Brashears et al 2003). This has been
postulated to relate to sound conditioning, the phenomenon by which prior
exposure to noise protects from further noise damage.
3.4.6 Audiological disorders: Auditory neuropathy/dys-synchrony
Reduced suppression is a common finding in auditory neuropathy/dys-
synchrony in patients with absent auditory brainstem responses and robust
TEOAEs (Hood, Berlin, Bordelon, and Rose 2003). This effect was
demonstrable to an impressive extent even with a small sample of 9 cases.
One hypothesis to explain this observation is that afferent dysfunction results
in inability to activate the efferent response (Berlin et al 2005; Hood, Berlin,
Bordelon, and Rose 2003).
3.4.7 Audiological disorders: Neonatal and paediatric hearing
assessment
Neonates with normal TEOAEs but risk factors for hearing loss showed lower
levels of suppression than full term neonates without risk factors (Durante
and Carvallo 2008). This observation may relate to lower levels of
neurological maturity in the high risk group, since, as discussed above, there is
a known maturational effect (Gkoritsa et al 2007). The authors emphasise that
this is a group effect and might not be detectable in individual cases, but
conjecture that reduced OAE suppression might be a risk factor for developing
hearing loss or auditory processing disorders. Since the subjects were selected
as being at high risk for hearing loss, it remains to be proven that abnormal
OAE suppression testing could provide information additional to what is
known from the clinical history. Abnormal suppression of TEOAEs by
contralateral noise was more common in children with auditory processing
disorder than those without (Muchnik et al 2004; Sanches and Carvallo
2006). This effect has also been noted in childhood selective mutism (Bar-
Haim et al 2004). If the MOC has a role in selective attention or noise
suppression, it may be, perhaps rather speculatively, hypothesised that MOC
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dysfunction could have a role in the development of specific language
impairment by disrupting language access. However, when this hypothesis
was investigated using TEOAE suppression by contralateral noise in a fairly
small sample of 20 diverse children with specific language impairment, no
evidence of such an effect was found (Clarke et al 2006).
3.4.8 Audiological disorders: Monitoring ototoxicity
Can OAE suppression predict susceptibility to ototoxicity from drugs such as
aminoglycosides or other ototoxic drugs? The clinical studies are not yet there
to answer this question, but one animal study suggested it may be possible
(Halsey et al 2005). In guinea pigs, rapid efferent adaptation of DPOAE to
noise predicted both number of days before onset of deafness and final
threshold shift.
3.4.9 Otoacoustic emission suppression testing for migraine?
Phonophobia, heightened sensitivity to sounds or noise which would not
normally cause distress, is listed as one of the key diagnostic symptoms in the
current International Headache Society (2004) definition of
migraine(International Headache Society Headache Classification Committee
2004). Similarly, the association of phonophobia with vestibular symptoms
such as head motion intolerance is one key criterion in Neuhauser’s diagnostic
schema for vestibular migraine(Neuhauser, Leopold, von Brevern, Arnold,
and Lempert 2001). The auditory efferent pathway assessed by otoacoustic
emission suppression is thought to have a role in modulating the gain of
auditory responses, and travels via the brainstem as outlined above (Figure
2.1). Otoacoustic emission suppression could therefore be hypothesised to be
particularly suitable to assess patients with vestibular migraine, in whom
significant brainstem dysfunction is known to occur (see Chapter 1.3), and in
whom the subjective experience of heightened sensitivity to auditory and
vestibular stimuli are a cardinal feature according to the standard diagnostic
criteria referred to above.
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This part of the study was therefore conceived to seek evidence of sensory
dysmodulation as a physiological correlate of the subjective experience of
heightened sensory sensitivity in vestibular migraine. The primary hypothesis
was that the patients with vestibular migraine would show more extreme
responses to auditory sensory stimuli than healthy controls, measurable using
OAE suppression.
3.5 Methods
3.5.1 Otoacoustic emissions protocol
The underlying methods for assessing OAE suppression were developed from
a published protocol developed in the same laboratory and with identical
systems to that to be used in this study (Ceranic, Prasher, Raglan, and Luxon
1998). This basic protocol will now be described.
External ears were required to be clean and free of wax and external debris.
Tympanometry was carried out to ensure normal middle ear function (GSI 33
Middle Ear analyser). Normal results were a type A trace according to Jerger’s
classification, with compliance between 0.3 and 1.4ml and pressure between -
100 and +100 daPa (Jerger J 1970). Pure tone audiometry was carried out
according to British Society of Audiology standard procedures on a GSI 61
Clinical Audiometer instrument. If the average pure tone threshold at 0.5, 1, 2
and 4 kHz was above 35 dB HL in either ear, or tympanometry was abnormal
patients and controls were excluded from OAE measurements (Kemp et al
1990). The procedure was carried out with subjects seated in a comfortable
chair.
Transient evoked otoacoustic emissions (TEOAEs) were recorded using the
non-uniform click at 80 dB SPL with 260 averages on an ILO92 system
(Otodynamics, UK (Kemp, Ryan, and Bray 1990) ). The non-uniform click
consists of three similar stimuli followed by one three times larger and of
opposite polarity. The effect of this reversal of polarity is to facilitate the
software in distinguishing artefact from genuine cochlear responses, since the
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former will show linear growth while the latter will saturate. The response
amplitude is calculated by the ILO92 hardware system over the frequency
range 500Hz to 6 kHz with a time window from 2.5 to 20.5 ms. The criteria
for defining presence of the TEOAE were that reproducibility should be
greater than 70% and the total response should exceed the noise floor level. If
TEOAEs were present with an overall amplitude of greater than 3.5 dB SPL,
testing proceeded to include suppression by contralateral noise.
The ILO88 software was set to Difference B on/off function. A uniform click
was presented at 60 +/-3dB SPL via the ipsilateral probe. The threshold for
white noise detection was ascertained in the contralateral ear via a second
insert probe. During testing, white noise was presented contralaterally at
40dB SL. The software then presents a series of runs, each of which comprises
60 responses below the noise floor, set at 48dB SPL. The time taken to obtain
60 responses therefore varied between subjects according to the background
noise level generated by that individual. The runs of 60 sweeps alternated
between the quiet condition (no contralateral noise) and noise condition
(white noise presented contralaterally according to parameters defined
above). This pattern of interleaving responses evens out any subject noise
across the quiet and noise conditions. The OAE suppression response was
taken as the difference between the amplitude of the response with
contralateral noise and the amplitude of the response without contralateral
noise. This was calculated for right and left ear for each individual.
3.5.2 The concept of total suppression
The technique as described above generates a measure of suppression for each
ear, i.e. two outcomes (right and left ear) for each individual. In other studies,
results have been analysed on the basis of each ear providing an independent
output (Coelho, Ceranic, Prasher, Miller, and Luxon 2007). There are two
reasons why this technique is not ideal for the purposes of this study. The first
is mathematical: statistical tests attach more weight to findings with an
increased number of measurements based on the assumption that the
readings are independent. However the two ears in an individual are clearly
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not independent measurements. In other words, mathematically speaking, it
might be possible, given the value of suppression in one ear, to make
predictions about suppression in the other. The second reason relates to the
nature of migraine as a condition. It is, essentially, a brain disorder, and there
is no reason to think that right ears should be affected any more or less than
left ears. In other studies, the right and left ears are analysed separately
(Hood, Berlin, Bordelon, and Rose 2003). This is also unsatisfactory for the
purposes of this present study, since it discards the information available from
the pairing between right and left ears in an individual. Therefore the concept
of total suppression, Ts, was devised. Ts is defined as the sum of suppression
values of the two ears in an individual, i.e. right ear (OAEq – OAEn) + left ear
(OAEq – OAEn). This analysis technique was designed incorporate all data
without erroneously claiming to have double the number of independent
recordings.
2.5.3 Establishing repeatability (intra-individual)
To assess repeatability of the OAE suppression measures, measurements were
repeated on 9 healthy subjects (18 ears). The second measure was taken at
least 24 hours after the first (range 24 hours – 4 months). The differences
between the value of suppression for each ear on the two occasions were
measured and the frequency distribution of the difference was plotted (Figure
2.3). The distribution of differences had a mean of 0.11, with a standard
deviation of 0.78. Since this analysis was concerned with the repeatability of a
particular measurement, regardless of the ear it was obtained from, ear
measurements from an individual were counted as distinct events.
The paired t test statistic is 0.577 (df 17), p=0.572, suggesting there is no
evidence of a systematic difference between the two occasions. The British
Standards Institution repeatability coefficient is 2SD = 2 x 0.776 = 1.552,
giving limits of agreement of 0.11 ± 1.552 i.e. -1.4 to 1.7. This gives an
intraclass correlation coefficient of 0.818, p=0.001.
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Figure 3.3 Distribution of the differences between first and second measures
of OAE suppression in separate ears
An identical procedure was carried out for total suppression Ts, with the
results plotted in figure 2.4. The paired t test statistic is 0.37 (df 8), p=0.752,
suggesting there is no evidence of a systematic difference between the two
occasions. The British Standards Institution repeatability coefficient is 2SD =
2 x 0.811 = 1.622, giving limits of agreement of -1.5 to 1.7. This gives an
intraclass correlation coefficient of 0.946, p=0.000.
These results suggest that the measurement of OAE suppression using this
technique is highly repeatable, both for separate ears and for total suppression
Ts.
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Figure 3.4 Distribution of the differences between first and second measures
of OAE suppression using total suppression Ts
3.5.4 Optimisation of technique: Is “dB thr” a useful concept?
De Ceulaer and colleagues reported that the optimal stimulus level is
determined by relation to the threshold of stimulus at which an OAE is just
recordable, termed “dB thr” (De Ceulaer, Yperman, Daemers, Van Driessche,
Somers, Offeciers, and Govaerts 2001). They record that the optimal stimulus
for presentation is at 12dB thr, the level at which suppression is largest. This
technique, whilst intuitively appealing, has not been adopted or replicated by
other groups. Therefore an exploratory study to evaluate the hypothesis that
larger values of suppression could be obtained by adoption of the dB thr
method was devised.
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External ears were required to be clean and free of wax and external debris.
Tympanometry was carried out to ensure normal middle ear function (GSI 33
Middle Ear analyser). Normal results were a type A trace according to Jerger’s
classification, with compliance between 0.3 and 1.4ml and pressure between -
100 and +100 daPa (Jerger J 1970). All ears had pure tone auudiometry
thresholds <20dB HL from 500 Hz to 8 kHz inclusive. The procedure was
carried out with subjects seated in a comfortable chair in a sound treated
room.
For each ear, a two part protocol was followed:
Part 1: Establishing dB thr
The stimulus and recording probe was sited in the ipsilateral ear. The noise
probe was sited contralaterally. Threshold for perception of white noise
presented contralaterally was ascertained, and then presented at 40 dB SL. dB
thr was then determined by the following technique. The uniform click
stimulus was presented at 60 dB SPL and then increased or decreased by 3dB
according to the presence or absence of an OAE recording with reproducibility
of >70% and amplitude just visibly above the noise floor. The number of
accepted responses was set at 260. dB thr was defined as the minimum
stimulus presentation level required to produce an OAE recording with
reproducibility of >70% and amplitude just visibly above the noise floor.
Part 2: Establishing optimal suppression relative to dB thr
The OAE was recorded with 260 accepted responses using a stimulus of 0 dB
thr, first with and then without contralateral white noise at 40dB SL. This
process was repeated with the ipsilateral click stimulus presented at 0, +3, +6,
+9, +12 and +15 dB above dB thr.
For each of the five ears in the study, the value of suppression was plotted
against ipsilateral click intensity re dB thr. Values are shown below (Figure
2.5), with each line representing one series of recordings on one ear.
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Figure 3.5 dBthr against level of suppression in five ears
There was no consistent pattern with respect to the optimum level for
suppression, with two ears having maximum suppression at 0 dB thr, two ears
having maximum suppression at 6 dB thr, and one ear having maximum
suppression at 15 dB thr.
The preliminary data from detailed study of five ears did not support the
hypothesis that using the dB thr technique would maximise suppression
values. Therefore this potential modification of the technique was rejected.
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3.6 Otoacoustic emission suppression results
3.6.1 General descriptors of participants
39 patients and 33 controls were assessed. TEOAEs were present bilaterally in
all controls. Of the patients, they were absent bilaterally in one 49 year old
woman with basilar migraine. TEOAE amplitudes were too small to record
verifiable suppression in at least one ear in five patients, who were thus
excluded from further analysis. Thus there were therefore 33 patients in the
main analysis. General descriptors of these patients and controls are shown in
Table 3.I.
Table 3.I. General descriptors of participants in OAE study
Controls Migraine group
n 31 33
Age (yrs) mean ±SD 36.1 ± 8.4 36.2 ± 9.2
% female 61 82
Aura symptoms according to IHS definition - 13 (39%)
Basilar type migraine - 9 (27%)
Years since onset of migraine attacks - mean 12, SD 11
range 0-41
Phonophobia - 29 (88%)
Other auditory symptoms with attacks - 17 (52%)
On migraine prophylaxis - 17 (52%)
Canal paresis in caloric testing - 13 (39%)
Directional preponderance on ENG - 8 (24%)
3.6.3 Otoacoustic emission suppression outcomes
To validate the suppression paradigm, a paired t – test was used to seek
evidence of a difference in amplitude. In both the vestibular migraine and
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control groups, a paired t test between the quiet (OAEq) and noise (OAEn)
conditions confirmed that significant suppression has occurred using this
protocol (Table 3.II). There was no significant difference between mean values
of suppression for right (mean 1.9 dB; SD 1.4 dB) and left (1.8 dB; SD 1.1 dB)
sided recordings for (p=0.7, t test).
Table 3.II OAE suppression results
Controls
n=31
Migraine group
n=33
Migraine vs.
Controls
Mann Whitney
U
OAEq-OAEn right ear /
dB
(median and IQR)
1.7 (1.3-2.6)
paired t test
p =0.000
1.4 (0.6-1.4)
paired t test
p =0.000
p =0.42
OAEq-OAEn left ear / dB
(median and IQR)
2.0 (1.2-2.4)
paired t test
p =0.000
1.7 (0.6-2.7)
paired t test
p =0.000
p =0.38
Total suppression /dB
(median and IQR)
3.3 (2.5-5.3) 2.8 (1.5-5.5) p=0.27
The vestibular migraine and control groups were compared to seek a
difference in mean values of suppression. Since the data were not convincingly
normal in distribution, non parametric tests were selected. Mann Whitney U
testing showed no difference in the mean value of suppression between
vestibular migraine patients and controls for either right or left ears, or for the
total value of suppression (Ts) in each individual. The frequency distributions
for total suppression are given in Figure 3.6.
Participants were also classified into those with normal suppression, where
total suppression was ≥2 dB, and those with abnormal suppression where the
total suppression was <2dB. 3/31 controls had low total suppression (Ts)
compared with 11/33 cases (p=0.022, Chi squared test). Phonophobia was
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present in 10/11 (91%) cases with low total suppression and 19/22 (86%) cases
with normal total suppression (Ts) (p=1), Fisher’s exact probability test).
Figure 3.6. Total suppression frequency distributions for controls vs. migraine
group
To account for the effect of multiple potential confounders, binary logistic
regression analysis was carried out to identify factors which had an effect on
the probability of being in the control or vestibular migraine groups. Age, sex,
and abnormal total suppression (Ts) were examined. Age and sex were not
significant predictors, and there were no significant interactions between
factors. Abnormal total suppression (Ts) was a significant predictor of
vestibular migraine (vs control) status (Table 3.III). This implies that
abnormal total suppression (Ts) is associated with vestibular migraine.
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Table 3.III. Binary logistic regression analysis to predict case-control status
Regression
coefficient B
Exp (B)
Odds ratio estimate
(95% confidence
interval)
Significance
level (p
value)
Age -0.013 0.987 (0.944-1.033) 0.573
Sex 0.506 1.659 (0.626-4.396) 0.308
Low total
suppression
Ts
-1.540 0.214 (0.053-0.863) 0.030*
To look for factors which identify the subgroup of vestibular migraine patients
with abnormal total suppression (Ts), a separate binary logistic regression
analysis was carried out. In this analysis, use of migraine prophylaxis,
duration of symptoms, cand presence of phonophobia were assessed as
predictors of low total suppression (Ts) (Table 3.IV). None was significant.
Table 3.IV. Binary logistic regression analysis to predict low total
suppression in participants with vestibular migraine
Regression
coefficient
B
Exp (B)
Odds ratio estimate
(95% confidence
interval)
Significance
level (p
value)
disease
duration
0.023 1.024 (0.956-1.096) 0.528
phonophobia -0.129 0.879 (0.068-11.380) 0.921
migraine
prophylactics
-0.218 0.770 (0.186-3.470) 0.770
canal paresis -0.685 1.112 (0.093-2.725) 0.426
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3.6.3 Ictal and interictal comparison
In three patients, OAE suppression recordings were obtained both during an
attack of vestibular migraine (ictal condition) and when well (interictal
condition), illustrated in Figure 3.7.
Figure 3.7 Ictal and interictal measures for total OAE suppression. In normals, the
maximum amplitude of change between two recordings was 1.7 dB.
In the repeatability study, the 95% confidence interval for the difference
(mean±2SD) for Ts1 - Ts2 was -1.5 to 1.7 dB (see section 3.5.3 above). For two
of the cases, the change in total suppression was considerably outside of the
normal range (3.1dB and 2.7dB). It is noted that these changes are in opposite
directions so that in one patient suppression reduced with recovery from an
attack of vestibular migraine and in the second it increased. In the third case
the change in total suppression was within the normal range (Ts1 - Ts2 = 1.2).
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3.7 Discussion
Otoacoustic emission suppression testing was established as a repeatable test,
and significant suppression was confirmed in a healthy, non-migrainous
population. Modification to the standard OAE suppression technique in the
form of dB thr was rejected after pilot data failed to support the hypothesis
that this would increase the amplitude of the response.
This study then evaluated the auditory efferent pathway in individuals with
vestibular migraine, looking for evidence of impaired sensory modulation in
the auditory modality.
OAE suppression was clearly demonstrated in both the vestibular migraine
group and in the control group, with no significant difference in amplitude
between left and right ears. However, total OAE suppression by contralateral
noise assumed a low value in patients with vestibular migraine (33%) more
frequently than in controls (10%) (p=0.022). Abnormally low values of total
suppression were associated in the binary logistic regression analysis with
presence of vestibular migraine. Symptoms of phonophobia were not shown to
relate to low suppression.
Reduced OAE suppression could occur due to problems anywhere along the
reflex arc from the outer hair cells through the auditory nerve, central
pathways via the cochlear nucleus, trapezoid body and superior olivary
complex, through the crossed and uncrossed olivocochlear bundles and the
efferent pathway via the inferior vestibular nerve; or, indeed, by affecting top-
down modulation via corticofugal pathways from the auditory cortex (Perrot
et al 2006). It is known that audiometry is usually normal in migraineurs with
dizziness symptoms (Battista 2004). Given current understanding about the
pathophysiology of migraine, and the fact that sensory dysmodulation occurs
across different modalities it seems likely that the source of the dysfunction in
this case is at the level of processing in the brainstem or higher structures,
rather than occurring in the peripheral labyrinth or cochlea.
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These patients might perhaps be expected to have a higher rate of vestibular
dysfunction, since they have, by definition, significant vestibular symptom
load. This could be a potential confounder, since a high rate of (inferior)
vestibular nerve dysfunction could be associated with abnormal total
suppression. However, there was no relationship between canal paresis
(indicative of superior vestibular nerve function) and OAE suppression.
Results and analysis discussed later in this thesis also show there was no
relationship between OAE suppression and VEMP abnormalities (see chapter
4.9.5).
During the execution of this study, some data on OAEs in individuals with
migraine were published (Bolay et al 2008). The authors of this study record
that there is a statistically significant difference between TEOAE amplitude in
quiet and contralateral noise conditions in healthy controls, but not in
migraineurs. This result is of interest, but there are methodological
limitations. The analysis depends on pooled data for noise and quiet
conditions, rather than making use of paired data for each individual.
Additionally the eliciting stimulus was set at 83 dB SPL, and a role of middle
ear reflexes cannot be excluded at this high level of sound intensity, so it is
difficult to localise the lesion. The methodological differences may account for
the fact that, although the work presented in this thesis did find abnormalities
in suppression, it does not replicate the primary observation made in this
previous study.
There was no demonstrable relationship between abnormal OAE suppression
and either clinical symptoms heightened auditory sensitivity (phonophobia)
or other factors such as age, gender or time since onset of first migraine
symptoms. Therefore although it is clear that there is a subgroup of patients
with vestibular migraine who have abnormal OAE suppression, it has not been
possible to identify a common factor amongst this subgroup.
The mechanism of phonophobia is not well understood. One quantitative
study showed that migraineurs had lower sound aversion thresholds than
controls interictally, with even lower thresholds ictally (Ashkenazi et al 2009).
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The observation that hearing thresholds often reduce with an associated
increase in dynamic range during migraine attacks suggests that cochlear
recruitment is not likely to be cause of phonophobia (Woodhouse and
Drummond 1993). Loss of efferent suppression is a plausible alternative
hypothesis. However, there was no demonstrable relationship between
abnormal OAE suppression and phonophobia in our study. The mechanism of
phonophobia may not relate directly to auditory efferent function as measured
by OAE suppression. There may be a dissociation between the subjective
experience and the objective measurement. It is known that there is
considerable variability in patients’ responses to questions about sound
sensitivity which is an essentially subjective experience (Evans et al 2008).
This may make it difficult to demonstrate a difference between “phonophobic”
and “non-phonophobic” individuals. The intensity of phonophobia also varies
in an individual over time, both between the ictal and interictal conditions,
but also from attack to attack. Comparing OAE suppression recorded ictally
and interictally in three patients however still showed no clear pattern of
abnormality. There are variations in the degree of phonophobia, it being very
marked in some patients but only mild in others (Woodhouse and Drummond
1993), and it may also be that loss of suppression is only a relevant
mechanism in an as yet unidentified subgroup of those with phonophobia.
It is noted that in two out of three cases, there is a high degree of change
between the ictal and interictal conditions. This was in opposite directions, so
that in one case the suppression reduced with recovery and in one it increased.
This is a small sample and as such it may be difficult to generalise from this
observation, but it is certainly in keeping with dysregulation of the pathways
serving OAE suppression, with variable direction of dysregulation.
3.8 Conclusion
OAE suppression is reduced in a third of individuals with vestibular migraine.
This objective phenomenon does not have a simple relationship to the
subjective experience of phonophobia. When comparing ictal and interictal
recordings, the responses show a high amplitude of change, but with variable
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direction. These observations can be construed as evidence in support of
auditory efferent pathway dysfunction in vestibular migraine.
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Chapter 4. Use of vestibular evoked myogenic
potentials in the assessment of vestibular
migraine
4.1 Overview of vestibular evoked myogenic potentials
Vestibular evoked myogenic potential recordings (VEMPs) have become
established as a test of a neuro-otological (sacculo-collic) reflex (Welgampola
and Colebatch 2005). Surface electromyographic (EMG) activity is recorded
from the sternocleidomastoid (SCM) muscle in response to sound stimuli. The
reflex is carried from the saccule through the inferior vestibular nerve,
vestibular nuclei and the medial vestibulospinal tract via the medial
longitudinal fasciculus, and thence to the sternocleidomastoid in the eleventh
cranial nerve (Figure 4.1). The response measured is a biphasic, inhibitory,
short latency potential. The initial positive peak occurs at around 13 ms
followed by a negative peak at around 23ms (Figure 4.2). Later responses are
frequently seen but are not reliably present in normal subjects (Colebatch et al
1994) .
Figure 4.1 VEMP assesses the sacculo-collic reflex.
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Figure 4.2 VEMPs are a biphasic inhibitory short latency response
It has long been known that the vestibular system in humans responds to
sound stimuli. Bekesy observed in 1935 that a sense of motion and
involuntary head movements occur towards an ear stimulated by sound. The
technique as it is now recognised was pioneered by Bickford et al in 1964
(Bickford et al 1964), and then developed into that used today by Colebatch
and colleagues in 1994 (Colebatch, Halmagyi, and Skuse 1994). Bickford was
in fact investigating the reliability of using computer averaging to record
cortical evoked auditory responses, but noted that there were “unexpected
observations which suggested that the phenomenon should receive additional
study”, namely “large and invariant early waves”. This group also correctly
identified that the response was myogenic rather than neural in origin. They
noted that it was absent in an anaesthetised and “partially curarized” subject
and a patient with absent labyrinthine function but present symmetrically in
patients with complete unilateral or bilateral sensorineural hearing loss and
preserved caloric responses. Later, Colebatch et al recorded responses from
the anterior neck muscles rather than the inion (which Bickford was using),
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and showed that the response is present in patients with profound unilateral
or bilateral sensorineural hearing loss with apparently normal vestibular
function. This group also noted that the early responses (named p13-n23)
were abolished in the operated ear of patients who had undergone vestibular
nerve section, but present on the intact side.
4.2 Stimulus factors
Clicks and tone bursts are both used as sound stimuli, with tone burst evoked
VEMPS showing similar properties to click evoked VEMPs (Murofushi et al
1999). The dependence of amplitude on stimulus frequency of tone burst
VEMPS can be plotted, and shows a pattern akin to the tuning curves of
auditory nerve fibres, with maximal response at 500Hz to 1kHz (Rauch et al
2004). In general, a lower stimulus intensity is required for tone bursts as
opposed to clicks. VEMPs have also been recorded using galvanic stimulation
and through bone conduction via skull taps with a tendon hammer or bone
conducted tones. The stimulus can be delivered either monaurally or
binaurally. Although there are apparently no significant differences between
the monaural and binaural response conditions (Wang and Young 2003),
most investigators prefer for research purposes to use a monaural stimulus
and response to reduce the risk of contamination by crossover effects. The
threshold for recording robust and repeatable responses is around 85-100dB
nHL for clicks (Colebatch, Halmagyi, and Skuse 1994). The amplitude of the
response depends directly on sound stimulus intensity. 100dBnHL clicks
produced normal responses in 75% normals in another study (Robertson and
Ireland 1995). This sound intensity is at the upper limit of what is considered
safe, but most subjects tolerate the sound stimulus well. The optimal click
repetition rate, balancing competing factors of variance, test comfort for
patients and duration of testing time, is reported to be 5/s (Wu and Murofushi
1999).
VEMP responses as described above are sometimes referred to as cervical
VEMPs (c-VEMPs) to distinguish them from the more recently developed
ocular VEMP (o-VEMP). The bone conductor stimulated o-VEMP response is
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quite distinct from the air conducted c-VEMP response, being an excitatory
response thought to be primarily utricular in origin (Nguyen et al 2010). The
work described in this thesis relates purely to air conduction stimulated c-
VEMP recordings.
4.3 Other factors affecting properties of the response
It has been recognised that, unsurprisingly, outer and middle ear factors
which impede sound transmission (conductive hearing loss of any aetiology)
can abolish or attenuate the response where air conducted stimuli are used
(Bath et al 1999). The amplitude of the response also depends on the level of
tonic EMG activation in a linear fashion (Colebatch and Halmagyi 1992). Raw
amplitude is a highly variable parameter between individuals (Ochi et al
2001). Maintaining muscle activation in a controlled fashion around 50 µV
minimises amplitude variability, and using a visual feedback technique
improves reliability (Vanspauwen et al 2006). Electrode placement also
affects response amplitude, with the optimal placing identified as on the
middle third of the sternocleidomastoid muscle (Sheykholeslami et al 2001).
The response to clicks is almost invariably present in individuals under 60
years old (Welgampola and Colebatch 2005) but amplitude is known to
decrease with increasing age (Brantberg et al 2007). The reference electrode
can be sited on the mid-clavicle, sternum or forehead (Welgampola and
Colebatch 2001). The method used to activate SCM is very variable between
institutions, but is presumably irrelevant if target tension is measured and
maintained using visual biofeedback.
4.4 Anatomical correlates
Otololith afferents are known to respond to intense sound stimulation (McCue
and Guinan, Jr. 1994; McCue and Guinan, Jr. 1995; Murofushi and Curthoys
1997). In monkeys, saccular afferents have the lowest thresholds to sound
stimulation (Young et al 1977). In other animal studies, stimulation of the
saccular nerve results in a similar inhibitory response in about two thirds of
sternocleidomastoid neurons. Utricular nerve stimulation, by contrast, evoked
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excitatory responses (Uchino 1997). There is also evidence from studies in
patients with inner ear anomalies suggesting that the response is primarily
saccular (Sheykholeslami and Kaga 2002).
Acoustic startle reflexes are characterised by longer latencies, prolonged
refractory periods and rapid habituation (Brown et al 1991). Although VEMPs
are known to habituate in normal subjects (Roceanu et al 2008), they are not
seen to have prolonged refractory qualities. The short latencies of the VEMP
suggest a disynaptic pathway is responsible for generation (Colebatch and
Halmagyi 1992). The response is thought to be mostly ipsilateral via the
medial vestibulospinal tract with only weak contralateral effects. However,
VEMPs have been recorded in some subjects after vestibular nerve section
with intact cochlea and cochlear nerves (Ferber-Viart et al 1998). The
response is generated by the surface EMG of the sternocleidomastoid muscle.
4.5 Clinical applications
The most striking clinical application of the VEMP has been in the evaluation
of the Tullio phenomenon, in which individuals experience symptoms of
dizziness or imbalance in response to loud sounds (Colebatch et al 1998). It is
caused by presence of a “third mobile window” allowing undampened
transmission of sound energy into the labyrinth. These disorders include
superior semicircular canal dehiscence and perilymph fistula. It has been
shown that patients with superior semicircular canal dehiscence diagnosed by
high resolution CT scans have abnormally low VEMP thresholds and
associated high amplitudes.
VEMPs have also been shown to be abnormal in eighth nerve pathologies such
as cerebellopontine angle tumours including vestibular schwannomas
(Matsuzaki et al 1999). Multiple sclerosis patients can have prolongation of
latency (Murofushi, Shimizu, Takegoshi, and Cheng 2001). As might be
expected, there are variable findings in clinical studies of brainstem strokes,
with VEMP absence, latency prolongation and reduction of amplitude all seen
as well as normal responses in some cases (Pollak et al 2006). Low VEMP
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amplitude and high threshold are seen in seasickness susceptible individuals
(Tal et al 2006).
4.6 Limitations of technique
Tinnitus is a relative contra-indication, and subjects must endure sounds of
high intensity (120 dB SPL) which some find difficult to tolerate. Subjects
must maintain SCM activation by head flexion and/or lateral head turn, with
or without resistance. Subjects with back or neck pain may find this difficult.
The technique also has limited clinical applicability thus far, with superior
semicircular canal dehiscence being the only application where VEMPs show a
high degree of diagnostic sensitivity.
4.7 VEMPs in migraine
Patients with vestibular migraine are known to have evidence of significant
vestibular brainstem dysfunction ictally (von Brevern, Zeise, Neuhauser,
Clarke, and Lempert 2005), and variable reports of peripheral and central
vestibular dysfunction in the interictal period (Furman, Marcus, and Balaban
2003). It might therefore be expected that study of a technique that assesses
vestibular brainstem function could yield insights into the pathogenesis of
VM. In a study of benign paroxysmal vertigo of childhood (Chang and Young
2007), thought to be a migraine precursor, 30% cases had absent VEMPs, and
this study also reports that latency abnormalities were fairly common. At the
time of conception of this study, however, there was but a single report of
VEMPs in migraine (Liao and Young 2004). This was a study of 20 basilar-
type migraine patients, and showed abnormalities of presence, latency or
threshold in 10 (50%). These patients have a very distinct presentation from
vestibular migraine. The observed abnormalities resolved in 9/10 with three
months treatment with flunarizine 10mg. During the execution of this present
study further reports have evolved. Two groups have reported a reduction in
mean amplitudes (Allena et al 2007; Baier et al 2009), one has reported
reduced habituation of the VEMP response (Allena, Magis, De Pasqua, and
Schoenen 2007), and reported that migraineurs with and without vertigo have
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similar results (Roceanu, Allena, De, V, Bisdorff, and Schoenen 2008). On the
other hand it is also reported that the majority of individuals with VM have
normal VEMPs (Vitkovic et al 2008), albeit in a study where the VEMPs were
not the principal outcome of interest and the technique and results are not
reported in detail. Review of these studies suggests some heterogeneity of
findings (summarised in Table 3.I), and the need for further confirmatory
study is thus apparent.
Table 4.I VEMP findings in previous studies of migraine
Study Subjects Principal VEMP findings
Liao (2004) basilar migraine prolonged latency 15%, absent
VEMPs in 35%
abnormalities resolved with
treatment
Allena (2008) migraine and
migrainous
vertigo
reduced habituation and reduced
raw and normalised amplitude in
both groups
Vitkovic
(2008)
migrainous
vertigo
normal in 80%, rest inconclusive
Murofushi
(2009)
migraine
associated vertigo
Absence unilaterally in 1/11 at
1000Hz
Reduced 500Hz-1000Hz slope in
3/11
Prolonged p13 latency in 4/11
Baier (2009) definite or
probable
vestibular
migraine
reduced amplitude in 68%
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4.8 Methods
4.8.1 Participants
Exclusion criteria were a history of middle ear disease, otologic surgery,
conductive hearing loss, high-risk noise exposure, abnormal otoscopy or
tympanometry, or any other medical, neurological or orthopaedic disorder
likely to interfere with testing. Participants on drugs known to affect the
nervous system were excluded, with the exception of those on anti-migraine
treatments. All participants were between 16 and 60 years of age, as VEMP
data are less reliable in people over 60 (Welgampola and Colebatch 2005).
Normal controls were recruited from hospital staff, friends and colleagues.
Potential controls were excluded if they had a history of headaches with
migrainous features, a history of otologic disease or clinically significant
audiovestibular symptoms, or any medical, neurological or orthopaedic
disorder likely to interfere with testing. They were selected as a group to
match the age and sex distributions of the patients.
4.8.2 Vestibular evoked myogenic potentials protocol
Vestibular evoked myogenic potentials were recorded using a Medelec
Synergy system (Oxford Instruments, Surrey, UK). A 500 Hz tone burst
monaural stimulus was used via headphone with a repetition rate of 4.7/s, 2-
4-2 ms rise-plateau-fall time and Blackman filter. 200 sweeps were averaged
for each run. The 500Hz tone burst had been selected as a stimulus rather
than clicks due to lower sound intensity required and larger amplitudes in
preliminary recordings. Recordings were made with electrodes placed at the
midpoint of the ipsilateral sternocleidomastoid, using the midpoint of the
clavicle as a reference and the forehead as the ground. Subjects reclined on a
couch and activated sternocleidomastoid through neck flexion and lateral
head turn, in whatever combination the subject was able to maintain adequate
activation comfortably. EMG activation was maintained at 60-80 μV
throughout recording using a visual biofeedback technique. If VEMPs were
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absent at the first recording session, participants were invited back for repeat
testing on a subsequent occasion, several weeks later.
Measurements were made of threshold, amplitude and latency of the
waveforms. Amplitude was measured as the peak-to-peak difference between
the p13 and n23 components of the response. Raw amplitudes were corrected
for underlying EMG activity by dividing the raw amplitude (A RAW ) by the pre-
stimulus mean EMG (A EMG) i.e. normalised amplitude ratio = A RAW / A EMG.
Amplitude and latency measurements were made at 120 dB SPL, or 125 dB
SPL if the response threshold was 120 dB SPL. Maximum stimulus intensity
was 125 dB SPL, and responses were said to be absent if not recordable at this
level. An asymmetry ratio was computed for normalised amplitude (100 * ((AL
– AR)/ (AL + AR)) where AL is the normalised amplitude ratio on the left, and
AR the normalised amplitude ratio on the right (Welgampola and Colebatch
2005). A response was said to be present if waveforms were consistently and
repeatably present above the noise floor.
Since determination of response absence or presence could be perceived to be
subject to individual investigator bias, 22 traces were randomly selected and
presented to an independent reporter blinded to case-control status and to
previous reporting. For each of these ears, the reporter only had access to the
two traces with the highest stimulus presentation levels, but the intensity of
these stimuli was withheld (as this could give clues about the original report).
In addition, a small study was carried out to determine the repeatability of
VEMPs in a small sample of healthy subjects normalised amplitude, threshold
and p13 latency were measured on two occasions at least two weeks apart by
different investigators. The repeatability was assessed using the intraclass
correlation coefficient (ICC), and the distribution of differences between the
two measurements, using a two-way mixed effects model where people effects
are random and measures effects are fixed.
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4.9 Results
4.9.1. Repeatability
11 controls underwent VEMP repeatability studies. In one subject data were
only available on one ear due to time constraints, hence n=21.
Figure 4.3 is the frequency distribution for the difference between the first
measurement of normalised amplitude ratio and the second measurement .
ICC was -0.281 (95% confidence interval -4.159 to 0.682; F test with true
value=0 p=0.641). It shows wide variation with a poor ICC, suggesting poor
repeatability. Limits of agreement are calculated as -1.4 to + 1.5.
Figure 4.3.Frequency distribution of the difference between two measures of
normalised amplitude ratio (“allampdiff”)
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Figure 4.4 shows the frequency distribution for the difference between the
first and second measurements of threshold. ICC was 0.815 (95% confidence
interval 0.545 to 0.925; F test with true value 0 p=0.000). It shows a
maximum difference of ± 10 dB with a high ICC, suggesting good
repeatability. Limits of agreement for threshold are -11 to + 12 dB.
Figure 4.4 Frequency distribution of the difference between two measures of
threshold (“allthreshdiff”)
Figure 4.5 shows the frequency distribution for the difference between
measurement 1 of p13 latency and measurement 2. ICC was 0.796 (95%
confidence interval 0.497 to 0.917; F test with true value 0 p=0.000). It shows
a maximum difference of with a high ICC, suggesting good repeatability.
Limits of agreement are -1.3 to + 1.3 ms.
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Figure 4.5. Frequency distribution of the difference between two measures
of p13 latency (“allp13diff”)
In summary, these data, in keeping with previous findings in the literature,
show good repeatability for latency and threshold but poor repeatability for
amplitude.
4.9.2 Basic descriptors of participants
35 patients with definite migrainous vertigo (Neuhauser, Leopold, von
Brevern, Arnold, and Lempert 2001) and 30 controls were recruited, with
characteristics as set out in table 4.II.
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Table 4.II Characteristics of patients and controls
Patients Controls
Mean age 37 yrs (SD 11) 38 yrs (SD 9)
% female 74% 70%
Duration of migraine attacks Range 0-47
yrs
(mean 15)
-
Aura symptoms 37%
(20% basilar)
-
Auditory symptoms with attacks 51% -
Phonophobia 71% -
On migraine prophylaxis 49% -
Canal paresis on caloric testing 33% -
Directional preponderance on ENG impulsive rotation
>25%
27% -
Central signs on ENG recordings 9% -
4.9.3 VEMP results
To examine the potential for investigator bias in reporting “absent” traces, the
reporting of responses as “present” or “absent” was investigated further using
a blind reporter technique. All identifying information including case-control
status was removed from a random sample of 22 traces, including 5 traces
originally reported as “absent” and 17 originally reported as “present”. The
blinded investigator reported the traces with a 100% concordance for both
“absence” and “presence”, suggesting minimal investigator bias in reporting of
absence of repeatable response.
VEMPs were demonstrably present in all control ears on the first recording
session (Figure 4.6). On first assessment, they were absent in three VM
patients bilaterally and in four patients unilaterally. In three of these ears with
absent waveforms, recordable waveforms were present at the second session.
One participant with a unilaterally absent VEMP declined repeat testing.
Therefore there were six ears in which VEMPS were consistently absent, in
addition to one in which the recording could not be repeated. VEMP absence
was unilateral in four cases and bilateral in one case. The proportion of cases
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with persistent VEMP absence in at least one ear is therefore 5/35 cases
(14%), compared with 0/30 in the control group (p=0.06, Fisher’s exact test).
Considering only the VM group, there was no relationship between VEMP
absence and age, disease duration, presence of canal paresis on caloric testing,
aura, tinnitus, hearing loss or symptoms of phonophobia.
The relationship between subjective clinical state and fluctuations in VEMP
presence was examined (Figure 4.7). There were too few measurements to
attempt statistical analysis, but half the six patients fell on the line of complete
correlation between VEMP improvement and subjective clinical improvement.
Figure 4.6. Presence of VEMP waveform at 125 dB SPL or below on
recording over two sessions
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Figure 4.7. Change of clinical state shown with respect to VEMP absence and
presence where “VEMP better” indicates a VEMP presence which had
previously been absent, and “VEMP worse” indicates VEMP absence where a
response had previously been present. The vertical (z) axis represents number
of individuals.
Student’s t-test was used to compare means in VM patients with recordable
VEMPs and controls for amplitude, threshold and latency where distributions
were approximately normal, and the Mann-Whitney U test for other
distributions (Table 4.III). There was no significant difference between
patients and controls for the mean values of p13 latency, normalised
amplitude ratio or threshold.
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Table 4.III. VEMP results. Variables are reported as mean ± standard
deviation unless stated otherwise.
VEMP parameter Ear VM group
(n=31 right
ears; n=32
left ears)
Controls
n=30
p value
Threshold /dB SPL right 112±8.6 113±6.5 0.93 t
test
Threshold /dB SPL left 111±7.3 112±7.3 0.41 t test
Interaural threshold
difference / dB SPL
interaural 5.2±4.0 4.7±4.3 0.64 t
test
Normalised amplitude
ratio
right 0.97±0.5 1.1±0.6 0.28 t
test
Normalised amplitude
ratio
left 1.0±0.6 1.3± 0.7 0.07 t
test
Interaural amplitude
difference
(Asymmetry ratio)
interaural 22.4±17 22.2±15.0 0.97 t
test
p13 latency /ms right 15.6±1.4 15.3±1.0 0.26 t
test
p13 latency /ms left 16.0±1.4 15.7±1.3 0.16 t test
Interaural p13
difference / ms
(median and IQR)
interaural 1.5 (0.4-2.4) 1.0 (0.6-
1.4)
0.23
Mann
Whitney
U
Using an identical protocol, previous independent work using the same
equipment on a set of 40 unrelated healthy volunteers, had defined normal
ranges for threshold, amplitude, latency and presence of response. Individual
patients or controls were then classed as either having normal responses, if all
data were within the normal range, or abnormal responses, if any parameter
fell outside the normal range. Study data were compared with these normal
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ranges to define the proportion of patients and controls that had abnormal
VEMP responses (Table 4.IV).
Table 4.IV. For patients, VEMP results outside departmental normal range
VM Patients Controls p value
Abnormal VEMP 11/35 3/30 (10%) p=0.036
VEMP absence 5/35
1 bilateral
4 unilateral
0/30 p=0.057
p13 latency
(normal range
3/35 1/30 p=0.2
Threshold
(normal
1/35 0/30 p=1
Amplitude
(normal
5/29 3/30 p=0.37
Binary logistic regression analysis showed that, taking into account age and
gender effects, the presence of a history of vestibular migraine was a
significant determinant of VEMP abnormalities, i.e. the patients with VM had
a higher rate of VEMP abnormalities than the controls (Table 4.V; p=0.008).
There was no relationship between the presence of canal paresis and the
absence of VEMP response. On the right side, two ears with absent VEMPs
also had canal paresis and two did not. Six ears also had canal paresis and
normal VEMP (Fisher’s exact test p=0.241). On the left side neither of the two
ears with absent VEMPs had canal paresis. Three ears with canal paresis had
normal VEMP (Fisher’s exact test p=1.00).
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Table 4.V Binary logistic regression analysis to predict case (VM)-control
status
95% C.I.for Exp(B)
B Sig.
Exp(B)
Odds
ratio
estimate
Lower
limit
Upper
limit
Any
parameter
outside
departmental
norms
1.642 0.008 5.167 1.527 17.481
age -0.020 0.467 0.980 0.928 1.035
sex 0.597 0.335 1.817 0.540 6.113
4.9.4 VEMP recordings in the ictal condition
In three individuals, VEMPs were recorded in the ictal and interictal
conditions. Normalised amplitude ratio, latency, and threshold were
compared according to known repeatability parameters (see section 4.9.1
above). These data are illustrated in Figure 4.8, 4.9 and 4.10 respectively.
There were no changes outside the normal range with respect to threshold or
amplitude. Two individuals had one ear in which the difference in latency was
outside the normal range of ±1.3 ms (described in 4.9.1 above), with the actual
differences being -3.2 and +1.6 ms.
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Figure 4.8 a). Raw data for change in normalised amplitude ratio in the ictal
and interictal condition in three individuals (six ears, marked by study ID
number and then R or L indicating right or left respectively). b) Frequency
distribution for the difference between ictal and interictal recordings for these
data
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Figure 4.9 a). Raw data for change in latency in the ictal and interictal
condition in three individuals (six ears, marked by study ID number and then
R or L indicating right or left respectively). b) Frequency distribution for the
difference between ictal and interictal recordings for these data
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Figure 4.10 a). Raw data for change in threshold in the ictal and interictal
condition in three individuals (six ears). b) Frequency distribution for the
difference between ictal and interictal recordings for these data
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4.9.5 Comparing VEMP findings and OAE suppression findings
The pathways for VEMP and OAE suppression have some common
components (figure 4.11), and the majority of VM participants (33/41) had
both VEMP and OAE recordings. The data were thus examined to seek
evidence of a relationship between VEMP and OAE results. There was no
correlation between VEMP amplitude and OAE suppression. The mean value
of suppression for those VM ears with absent VEMPS was 1.0 dB (n=5, SD
0.75), whereas for those with VEMP present it was 1.9 dB (n=52, SD 1.4)
generating p= 0.09 using the Mann Whitney U test. There was no significant
difference in the proportions of those with absent VEMPs amongst those with
low total suppression Ts (2/9) or with normal total suppression Ts (3/16;
p=0.5 Fisher’s exact test). The ictal-interictal results can also be compared
with OAE results (section 3.6.3 in the preceding chapter), since two out of the
three individuals in whom VEMPs were recorded ictally also had OAE
recordings on the same occasion (Table 4.VI).
Table 4.VI OAE recordings compared with VEMP recordings in the ictal and
interictal phases
Study ID
number
OAE ictal-interictal
comparison
VEMP ictal-interictal
comparison
MRD5 no recordings made normal
MRD17 abnormally large shift in Ts right ear showed large
increase in latency
MRD3 normal left ear showed large
reduction in latency
MRD19 abnormally large shift in Ts no recordings made
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Figure 4.11 Principal neural pathways for VEMP and OAE suppression showing
overlap via the inferior vestibular nerve (SCM sternocleidomastoid; SOC superior
olivary complex)
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VEMP
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lateral
noise to
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nuclei
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4.10 Discussion
The results from this study show a high rate of absent responses in the cases
of vestibular migraine (5/35 cases (14%)), compared with 0/30 in the healthy
control group (p=0.06). Regression analysis also shows that the VM group
had a higher overall rate of abnormal VEMPs when compared to the controls.
In addition, data from ictal and interictal recordings show latency shifts
outside the normal range in two out of three individuals.
This present study replicates Liao’s finding of absent VEMPs in a high
proportion of cases (Liao and Young 2004). This was also found by
Murofushi’s group to a lesser extent (Murofushi et al 2009). The stimulus
intensity in the VEMP protocol used in the present study is restricted to a
maximum of 125dB SPL, and it could be that VEMP absence in our study is a
representation of raised thresholds above this level. The finding of reduced
mean amplitude (Allena, Magis, De Pasqua, and Schoenen 2007; Baier,
Stieber, and Dieterich 2009) is not replicated.
What could be the possible reasons for the VEMP absence? Repeat assessment
by a blinded investigator showed a 100% concordance for interpretation of the
traces as present or absent suggesting that investigator bias is not a likely
explanation. Colebatch wrote in 2001: “The usual reasons for failing to record
robust responses are inadequate tonic activation of the sternocleidomastoid
muscles, confusion about the intensity of clicks required, or the presence of
conductive hearing loss …responses can be obtained in nearly all normal
individuals less than 65 years old.” In this study, the tonic activation of EMG
was recorded, measured and sustained using a visual biofeedback mechanism.
Presence or absence of response was determined at 125 dB SPL, the highest
level if output deliverable from the system. This is higher than the normal
upper limit in most studies. Conductive hearing loss or middle ear dysfunction
were excluded by tympanometry and audiometry prior to testing, and all
individuals participating were under 60 years of age.
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VEMP absence is reported in the literature to occur in some pathological
states, and only very occasionally in normals (Table 4.VI). To summarise the
information in this table, in 33 papers reporting VEMPs in various
populations, absence is reported in multiple sclerosis, benign paroxysmal
vertigo of childhood, brainstem strokes, dizzy clinic patients, HTLV with
cervical myelopathy, Meniere’s disease, sudden sensorineural hearing loss
with vertigo. Only two reported absence in normals.
Table 4.VII. VEMP absence in normals and patients
Study VEMP
stimulus
Number of
normals
Any absent
recordings
in normals?
Absent VEMPs in
patients?
Allena 2007 Click
95dBnHL
20 no No (in 25
migraineurs)
Aw 2006 Click 110dB
nHL
11 no 0/19 with superior
semicircular canal
dehiscence
Bandini 2004 100 dBnHL
click
21 no 0/36 with MS
Brantberg 2007 500Hz tone
burst 129 dB
SPL peak
0 0 1000 neuro-otology
patients (no
conductive hearing
loss or bilateral
vestibular failure)
?11 absences
Chang 2007 500Hz tone
burst at
95dBHL
20 children no 6/20 children with
benign paroxysmal
vertigo of childhood
Chen 2003 Click and
500Hz tone
burst at 95 dB
(reference not
specified)
“lab norms” not reported 5/7 with brainstem
stroke
Colebatch 1994 95dB nHL
clicks
10 no Absent unilaterally in
5 after vestibular
nerve section
Heide 1999 110 dB nHL
click
39 no 11/40 mostly
peripheral vestibular
disorder (0/6 with
“psychogenic
vertigo”)
Itoh 2001 Click 105 dB
nHL
21 no 1/13 brainstem
lesions
Felipe 2008 1kHz tone
burst
118 dBHL
30 no 10/72 HTLV patients
Ito 2007 500Hz TB 14 ?no -
Iwasaki and
Murofushi 2005
Click 95 dB
nHL
0 - 17/22 on affected side
idiopathic sudden
hearing loss with
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vertigo
Iwasaki and
Murofushi 2005
Click 95 dB
nHL
18 no 811 NO clinic
patients: identified 40
with absent VEMP
and present caloric
unilaterally
Kuo and Young
2005
500Hz tone
burst 95 dB
“lab norms” ?no 7/12 with Menières
Liao and Young
2004
500Hz TB 95
dB
“lab norms” ?no 7/20 with basilar type
migraine
Lee 2008 Click 95nHL 97 no -
Lim 1995 Click 95nHL 10 ?no -
Lin 2006 250, 500,
1000 Hz tone
burst at
90dBHL
12 no -
Murofushi 1998 Click
95dBnHL
8 no 15/21 vestibular
schwannoma
Murofushi 2001 Click
95dBnHL
18 no 15/43 MD affected
ear; 9/23 vestibular
neuritis; 39/62
vestibular
schwannoma; 3/12
MS
Ochi 2001 Click
95dBnHL
18 no -
Osei Lah 2007 500Hz TB 18 no -
Pollak 2006 Click
110dBnHL
53 no 0/34
cerebellar/brainstem
strokes
Rauch 2004 Click and
250,500,1,2,4
14 1 normal ear
no response to
click. 3 normal
ears no
response to
4kHz TB.
1/34 unaffected
Menière’s ears; 6/34
affected Menière’s
ears for clicks
Robertson and
Ireland 1995
Click
?maximum
stimulus
7 absent 25% -
Roceneau 2008 Click 95 dB
nHL
20 ?no ?0/17 migrainous
vertigo, 0/25 vertigo
free migraineurs
Sartucci 2002 Click 140 dB
SPL
15 no 0/15 with multiple
sclerosis
Seo 2008 Click
95dBnHL
10 no 0/18 “dizzy patients”
Takegoshi and
Murofushi 2000
Click
95dBnHL
9 no 0/10 olivopontine
cerebellar atrophy;
2/3 Machado Joseph
Vanspauwen
2006
500Hz tone
burst
15 no -
Versino 2007 145dB SPL
click
18 no 70 with multiple
sclerosis
Is the observation merely a statistical aberration, given a p value of only a
small amount below 0.05? Other groups do not publish reports of high levels
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of VEMP absence in normals, and so it seems likely that Colebatch is correct
to assert that, with correct technique, VEMPs are almost universally
recordable in normal individuals under 60.
Another possible explanation is the heterogeneous nature of vestibular
migraine. It is a clinical diagnosis, but is still fairly broad, and the community
of international experts on vestibular migraine are refining Neuhauser’s
original definition in a working party via the Barany Society. Is there a
synergistic mechanism at work with another pathology? For example,
Menière’s disease, which is known to affect VEMPs, can interact in a complex
way with migraine (Radtke, Lempert, Gresty, Brookes, Bronstein, and
Neuhauser 2002), as can vestibular neuritis (Best et al 2009b), and it is
conceivable that the predominantly migrainous presentation of some patients
masks an underlying alternative pathology.
Ultimately, then, we can consider the possibility that VEMP absence is
actually a feature of vestibular migraine due to underlying migrainous
pathology. This would suggest an abnormality of sensory processing or
response along the sacculocollic reflex arc, though the observation is not
specifically localising. Since some participants also had OAE suppression
recordings, which were largely normal, however, it can be seen that the
problem does not lie in complete malfunction of the inferior vestibular nerve.
Given what is known about migraine pathophysiology, thought of as a brain
disorder rather than one of peripheral or cranial nerves, this is perhaps
unsurprising. In the two individuals with both abnormal OAE suppression
and absent VEMPs, this could either be a chance finding (and there is no
evidence in this study to conclude otherwise). Alternatively, one might
speculate that an event such as an inferior nerve vestibular neuritis has been
the triggering event in these individuals. This could be investigated further
using video head impulse testing to delineate whether the posterior
semicircular canal was functional, but this facility was not available during
this investigation.
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Although VEMP abnormalities might be expected in migraine, in the context
of its current conception as disorder of sensory dysmodulation, one might
expect abnormalities such as disinhibition, lack of habituation or
hyperexcitability rather than absence of response. It should nonetheless be
acknowledged that there are other groups which have independently reported
similar findings (Liao and Young 2004). Reduction in amplitude is the other
principal finding in VEMPs in vestibular migraine (Baier, Stieber, and
Dieterich 2009). However, it is known that amplitude is a weak parameter in
VEMP recordings, with high variability (as shown in this study, Figure 4.3
above and elsewhere.
The ictal and interictal recordings obtained, albeit in a small number of
individuals, also show results of interest. Threshold and amplitude differences
between the ictal and interictal conditions were within normal limits.
However, there were large latency shifts unilaterally in two individuals, one
becoming shorter in the interictal condition and one becoming longer. It is
important to be wary of attaching too much importance to such a small
number of readings, but, for practical reasons related to testing an acutely ill
patient, it is difficult to obtain large quantities of data. These observations
need further independent verification.
4.11 Conclusion
VEMP abnormalities, including absence of response, are seen more frequently
than expected in cases of MV. This does not seem to be a result of technical,
experimental or statistical factors. The observed absence of VEMPs could be
due to the heterogeneous nature of VM and its interaction with other
conditions.
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Chapter 5. Vertigo as a migraine trigger
5.1 Introduction
Understanding migraine triggers is one key to understanding the
pathophysiology, and, potentially, the management of migraine. Triggers are
known to be diverse, ranging from phase of menstrual cycle, to sensory stimuli
such as noise (Martin, Reece, and Forsyth 2006), smells (Sjostrand et al 2010)
and glare (Kelman 2007), and even the more esoteric such as hair washing in
Indian women (Ravishankar 2006) and the Chinook winds of Canada (Cooke,
Rose, and Becker 2000). It has been reported that caloric testing, a potent
vestibular sensory stimulus, appeared to trigger migraine attacks in three
individuals (Seemungal, Rudge, Davies, Gresty, and Bronstein 2006). It is
also known that visual-vestibular stimuli such as optokinetic stimulation
(Granston and Drummond 2005) and motion sickness (Grunfeld and Gresty
1998) can trigger or exacerbate migraine symptoms. Migraineurs are also
reported to experience more nausea in response to vestibular stimulation in
the form of caloric testing (Vitkovic, Paine, and Rance 2008).
This combination of observations raises the possibility that vestibular
stimulation and the associated vertigo could be acting as migraine triggers,
although as yet there is a lack of systematic evidence for or against this
hypothesis. This section of the study was therefore conceived to examine the
hypothesis that vestibular stimulation, in the form of caloric testing, could act
as a migraine trigger.
5.2 Methods
Patients attending the Neuro-otology or Neurology clinics for the first time
were approached. Data were collected on age, gender, presenting complaint
and medication status. Participating subjects were classified, regardless of the
presenting complaint, as having a history concordant with International
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Headache Society (IHS) (2004) criteria for migraine (International Headache
Society Headache Classification Committee 2004) (migraineurs) or not (non-
migraineurs) based on a structured interview/questionnaire (appendix 4).
They were also assessed for conformity to the diagnosis of definite migrainous
vertigo according to Neuhauser (Neuhauser, Leopold, von Brevern, Arnold,
and Lempert 2001). Participants then underwent their standard clinic care as
determined by the treating physician. This either involved vestibular testing
(vestibular test group) or did not (control group). The protocol of the study is
illustrated in figure 5.1. This aspect of design was intended to control for the
stress of a hospital appointment and associated investigations as a new
patient, which could of itself act as a potential migraine trigger. Patients were
excluded if they experienced daily headaches of any kind, as it would be
difficult to identify a clear relationship between the stimulus and any
headache outcome in such cases.
Figure 5.1. Trigger study protocol
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All patients had horizontal direct current electro-oculography according to a
standard protocol: gaze testing (+/- 30° searching for nystagmus in the light
and darkness), sinusoidal rotation, vestibulo-ocular reflex suppression,
impulsive rotation, optokinetic stimulation and smooth pursuit. Sinusoidal
rotation was carried out in the dark during with a motorised chair at a
frequency of 0.2 Hz, peak velocity of +/- 30°/s for a duration of approximately
eight cycles. Ability to suppress the vestibulo-ocular was then tested by
repeating the sinusoidal stimuli and asking the patient to visually fixate on a
target which moves with them (i.e. stationary with respect to the patient), for
approximately four cycles. Impulsive rotation comprised velocity steps at +/-
60 °/s until nystagmus subsides (approximately 45 seconds, maximum of 100
seconds; approximate acceleration/deceleration (-140 °/s2). In full field
optokinetic testing the subject was stationary whilst the surrounding striped
curtain revolved at a speed of 40 °/s, alternating direction every 5-10s for a
total of approximately 30s. For smooth pursuit subjects were required to track
a laser-projected target moving in a sinusoidal fashion at 0.2, 0.3 and 0.4 Hz.
All patients in the vestibular test group underwent bithermal water caloric
testing using a 40 second irrigation in each ear at 44°C and 30°C.
Any patient who had rotation testing without calorics was excluded, since
rotational testing was deemed to be of insufficient potency as a vestibular
stimulus for the purposes of this study. To be eligible for the vestibular test
group patients were required to be naive to vestibular testing, since a previous
negative experience (including triggered migraine attacks) could be a reason
for refusal to undergo repeat testing, and this would bias results. Patients who
had vestibular testing were excluded from analysis if results showed bilateral
vestibular failure or if there was no subjective response to vestibular testing,
since the adequacy of vestibular stimulation in such subjects was in doubt.
Patients in the control group did not have induced vertigo (caloric/rotational
testing or positive response to positional testing) during their visit. All the
patients in the vestibular test group were recruited from the Neuro-otology
clinics, and those in the control group were predominantly from the
Neurology clinics.
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Participants were contacted after 24 hours by telephone or email to determine
any symptoms brought on during or after the hospital visit. If initial attempts
at contact were unsuccessful, further attempts were made up to a maximum of
two weeks after the initial visit. The principal outcome measure was the
occurrence of post visit migraine. The definition for post visit migraine was
derived from the IHS (2004) definition of migraine (International Headache
Society Headache Classification Committee 2004). Post visit migraines met
two out of three of criteria B, C and D in the IHS definition where criterion B
requires that the headache lasts 4–72 hours untreated or unsuccessfully
treated, C requires that the headache has at least two out of a set of
characteristic features (unilateral location, pulsating quality, moderate/severe
intensity and aggravation by routine physical activity) and D requires that the
headache is associated with one of either (i) nausea/vomiting or (ii) photo-
and phonophobia. This definition using two out of three criteria was selected
to overcome the difficulty that most patients took abortive medication so that
criterion B was not normally fulfilled. A post visit migraine was defined as
occurring within 24 hours of the hospital appointment, and patients were
asked to define if possible the time of onset of premonitory symptoms or
headache. Data were also collected on the presence of other types of headache,
other migraine symptoms, and whether vestibular symptoms (dizziness,
vertigo, imbalance) were present during a triggered migraine attack.
To account for the effects on outcome of multiple variables (age, gender, past
history of migraine or migrainous vertigo), binary logistic regression analysis
was used. Statistical testing was carried out using SPSS Statistics software
version 17.0 (www.spss.com).
5.3 Results
5.3.1. General descriptors
One hundred and forty eight (148) people were approached; five declined to
participate and 20 were excluded (five for daily headache, 12 were not
contactable within two weeks, three had bilateral vestibular failure or no
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subjective response to vestibular testing). There were therefore 123
participants in the study, comprising 79 in the vestibular test group (39
migraineurs and 40 non-migraineurs) and 44 in the control group (21
migraineurs and 23 non-migraineurs). The mean age was 43 in the vestibular
test group (SD 15, range 17-78) and 50 in the control group (SD 15, range 17-
75). The control group was 34 % male (15/44) and the test group was 30%
male (24/79); 8/44 (18%) controls were consulting for a form of migraine,
compared with 25/79 (32%) of the case group (p=0.11, χ2 = 2.61). 
Participants were consulting for a range of neurological and neuro-otological
disorders including migraine (30%), incompletely compensated vestibular
neuritis (17%), Menière’s disease (7%), central neuro-otological disorders
(15%), benign paroxysmal positional vertigo (3%), auditory disorders (11%)
and other neurological disorders (16%). Of the 60 migraineurs in the study, 23
(38%) met the Neuhauser criteria for migrainous vertigo (Neuhauser,
Leopold, von Brevern, Arnold, and Lempert 2001). All patients who had
vertigo as part of a positive response to positional testing were in the
vestibular test group. Four of the migraineurs were taking migraine
prophylactic agents at the time of assessment (three in the test group and one
control subject). Nine patients in the vestibular test group were taking
prescribed vestibular suppressant medications, but all had been advised not to
take them in the forty-eight hours preceding their assessment.
5.3.2 Headache outcome
The headache outcome for all four groups is shown in Table 5.I.
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Table 5.I. Headache outcome for all participants according to test group and
migraine history
Vestibular
test status
Past history
of migraine
(according to
IHS criteria)
n
No
post
visit
headach
e
Post visit
headache
(other
than
migraine)
Post Visit
Migraine
within 24
hours
Vestibular
tests
Migraineurs 39 15 (38%) 5 (13%) 19 (49%)
Controls Migraineurs 21 16 (76%) 4 (19%) 1 (5%)
Vestibular
tests
Non-
migraineurs
40 28 (70%) 7 (18%) 5 (12%)
Controls
Non-
migraineurs
23 19 (83%) 4 (17%) 0
Figure 5.2 illustrates the difference in headache outcomes for those with a
background history of migraine (migraineurs). Among the migraineurs, 19/39
(49%; 95% confidence interval 41 to 57%) of those in the test group
experienced a migraine within 24 hours, compared with 1/21 (5%; 95%
confidence interval 0 to 10%) of the control group who did not have vestibular
tests (χ2 =11.868 , p=0.001). Two participants from the test group who 
experienced migraines within 24 hours of the visit attributed the symptoms to
a specific alternative trigger (one to a difficult journey home, the other to the
phase of her menstrual cycle) and these cases were counted as negative
responses (“no headache”).
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Figure 5.2 Headache outcome for migraineurs in vestibular test and control
groups
Table 5.II shows the significance levels achieved for the variables entered into
the binary logistic regression model, which was designed to identity predictive
factors for post visit migraine. Vestibular testing, history of definite migraine
and history of migrainous vertigo were all significant factors. Of those
migraineurs who had vestibular testing, 14/21 (67%) of those with established
migrainous vertigo had post visit migraines, whereas only 5/18 (28%) of those
without established migrainous vertigo did so (χ2 = 5.867, p=0.015). 
Age and gender were not shown to have independent effects in this model, and
therefore these factors were not subject to further analysis.
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Table 5.II Binary logistic regression analysis of factors associated with post
visit migraine. P values less than 0.05 are marked with an asterisk *.
Factor P value Odds ratio
estimate (95%
confidence
interval)
Vestibular testing
(i.e. status within the test
group)
0.01*
14.6
(1.8-120.6)
History of migraine 0.05*
3.5
(1.0-12.8)
History of migrainous vertigo 0.04*
3.6
(1.0-12.5)
Female gender 0.47
1.6
(0.5-5.5)
Age 0.89
1.0
(0.96-1.04)
5.3.3 Associated features of triggered attack
There were 24 vestibular test group participants in whom post visit migraine
occurred. Symptoms of dizziness, imbalance or vertigo were experienced with
11 (46%) of these attacks. In the single control patient who experienced a post
visit migraine, no dizziness, vertigo or imbalance were reported. For 15
vestibular test group participants with post visit migraine, data were available
regarding the timing of the migraine attack. For seven of these 15 (47%), the
onset of migraine (premonitory symptoms or headache) was reported as
occurring during the induced vertigo i.e. the vestibular stimulus was time-
locked to the migraine response. One of these seven reported migraine onset
during rotation testing (which always occurred prior to caloric testing) with
the other six citing onset during caloric testing.
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5.4 Discussion
These results show that 49% of migraineurs experience a migraine headache
within 24 hours of a hospital assessment that included vestibular testing, in
contrast to only 5% of those migraineurs who had a hospital assessment
without vestibular tests. These results are in keeping with the hypothesis that
vestibular stimulation can be a migraine trigger (Seemungal, Rudge, Davies,
Gresty, and Bronstein 2006), since the probability of experiencing a migraine
in the study time window was significantly higher in the vestibular test group
than in the control group. As expected, a past history of migraine was also a
significant determinant of whether an attack was triggered. Although in this
study data were not collected on the frequency or severity of migraine attacks,
which could have introduced a bias between the test and control groups, the
proportions consulting for a migraine-related condition in the two groups
were not significantly different.
In 47% of those who had post visit migraine, the onset of migraine occurred
during the vertigo induced by vestibular tests. This is further evidence
indicating that it is the vestibular stimulus rather than the stress of a hospital
visit which has triggered the attack. This observation is in keeping with the
clinical observation that sensory stimuli in other modalities (audition,
olfaction, vision) are known to be migraine triggers. Patients not uncommonly
cite sensory stimuli as triggers (e.g. perfumes, fluorescent lighting (Kelman
2007)), and experimental paradigms using stimuli such as noise have
validated these reports (Martin, Reece, and Forsyth 2006).
A history of vestibular migraine also has a significant effect on the outcome.
Patients who have a diagnosis of definite vestibular migraine are more likely
to experience a migraine after vestibular testing than those with other forms
of migraine. Indeed, all the participants who underwent vestibular testing had
a history suggestive of vestibular disturbance, and it could be the case that
such subjects are particularly sensitive to vestibular stimuli as a migraine
trigger. The difference in outcome between the two groups might be somewhat
less marked if those in the test group had no such history. It is of note,
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however, that, despite using a vestibular stimulus to provoke an attack, fewer
than half the induced migraine attacks were associated with dizziness, vertigo
or imbalance which might suggest an attack of migrainous vertigo. This figure
is not dissimilar to the frequency of such symptoms in migraine attacks in
general (54.5% in one study (Kayan and Hood 1984)). Therefore it seems that
the vestibular stimulus is triggering migraine attacks through a final common
headache pathway which does not necessarily trigger the vestibular system.
Current understanding of the pathophysiology of migraine suggests a role for
both cortical and subcortical structures, and incorporates the concept of
sensory dysmodulation (Goadsby, Charbit, Andreou, Akerman, and Holland
2009). It is thought that the pain of migraine derives from activation of
trigeminovascular input to meningeal vessels, which is presumed to be the
final common pathway for initiation of migraine headache (Bolay et al 2002).
Migrainous aura is believed to be the result of a cortical process equivalent to
the animal model known as Leão’s spreading depression (Lauritzen 2001). It
is a matter of some debate whether attacks of migraine without aura originate
in the cortex or the brainstem. One hypothesis is that cortical activation is the
primary event, with descending pathways converging on brainstem nuclei
which regulate responses to sensory stimuli, such as the periaqueductal grey
and nucleus raphe magnus (Lambert and Zagami 2009).
There are therefore a number of putative mechanisms by which vestibular
stimuli could trigger migraines (Figure 5.3).
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Figure 5.3. Putative mechanisms for triggering of migraine headaches
Firstly, vestibular stimuli such as caloric testing cause activation of the
vestibular nuclei and thereby cortical structures, especially in the temporo-
parieto-insular areas (Dieterich and Brandt 2008). The vestibular nuclei have
connections to the dorsal raphe nucleus (Cuccurazzu and Halberstadt 2008)
and locus coeruleus (Nishiike et al 2001). Imaging studies show activation of
areas encroaching on the vestibular nuclei during an attack of migraine
without aura (Afridi, Giffin, Kaube, Friston, Ward, Frackowiak, and Goadsby
2005). The trigeminovascular reflex could thus be activated through these
cortical or subcortical pathways. Alternatively, it is theoretically possible that
trigeminovascular activation could occur as a direct consequence of peripheral
stimulation, by local release of neuroactive substances such as CGRP or
substance P. In support of this hypothesis, it is known that there is direct
innervation of vestibulocochlear structures by afferent trigeminal nerve
endings (Vass et al 1998b).This explanation is less likely given that the
triggered attacks do not specifically incorporate vestibular symptoms. Thirdly,
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there is the possibility that the migraines triggered in this study are occurring
due to a general stress or anxiety effect. It is well known that patients with
vestibular disorders find the experience of vertigo distressing and anxiety
provoking, and this is discussed elsewhere in this thesis (chapter 6, (Balaban
and Thayer 2001). In this part of the study, those undergoing vestibular
testing had a history of symptoms of dizziness, vertigo or imbalance. In such
patients, the concern that their symptoms would be reproduced by caloric
stimulation could be expected to produce some anxiety. The resulting
physiological stress response could be the trigger factor for the migraine
attack. However, many of the control patients also had potentially stressful or
aversive procedures such as blood tests or imaging on the day of their
appointment. This would tend to argue against the notion that the migraine
triggering effect of vestibular tests relates purely to stress responses. Other
sensory stimuli which act as migraine triggers are generally aversive (e.g.
noise, glare) although this is not exclusively the case (e.g. perfumes).
Whatever the mechanism, it is clear that induced vertigo from vestibular
stimulation is associated with the development of migraine attacks in around
half the migraineurs attending a Neuro-otology clinic. This observation can be
considered in the context of the known relationships between established
migraine and some disorders which cause episodic vertigo. It is reported that
the lifetime prevalence of migraine is increased in patients with Menière’s
disease (Radtke, Lempert, Gresty, Brookes, Bronstein, and Neuhauser 2002).
In this study 28% of the patients with Menière’s disease described typical
migrainous headaches as associated always or sometimes with their Menière
attacks. Our data suggest that this observation could be at least partly
explained by a trigger effect of the vertigo experienced as part of an attack of
Menière’s disease. Episodic ataxia type 2 is another disorder in which attacks
of vertigo have been reported to trigger migraine headaches (Baloh, Yue,
Furman, and Nelson 1997). Interestingly, attacks of ataxia (but not migraine)
can also be triggered by caloric stimulation in episodic ataxia type 1 (Vandyke
et al 1975). It is also reported in the literature that migraine is more common
than expected in cases of benign paroxysmal positional vertigo (BPPV) ( (von
Brevern et al 2007). It has been speculated that inner ear damage due to
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vasospasm in migraineurs could predispose to BPPV, explaining this
association. The data from this study suggest another possible contributory
mechanism: there could theoretically be an unmasking effect of BPPV on
migraine whereby episodes of BPPV act as triggers in susceptible individuals,
thus apparently increasing the frequency of attacks of migraine headache.
5.5 Conclusions
These data therefore have implications for clinical practice. Where a patient
gives a history of vertigo followed closely by a migraine headache, the
diagnosis will commonly be migrainous vertigo or basilar-type migraine.
However, some other disorder which causes episodic vertigo could be acting
as a migraine trigger in this individual. In order to reduce the migraine attack
frequency in such a patient, such a disorder would need to be identified and
appropriately treated. Such attacks could be thought of as a “secondary” form
of vestibular migraine, to distinguish it from a “primary”, intrinsic vestibular
migraine. The study suggests further avenues for research to characterise and
quantify the relative prevalences of primary and secondary vestibular
migraines.
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Chapter 6. Psychopathology of vestibular
migraine: what is the mechanism?
6.1 Introduction
It is well known that there is a higher prevalence of psychopathological
symptomatology, especially symptoms seen in depressive and anxiety disorders, in
both individuals with migraine (Jelinski et al 2007) and in individuals with vestibular
disease (Eagger et al 1992). It is also known that, among psychiatric outpatient
populations, there is an exacerbation of depressive symptoms associated with
migraine attacks (Hung et al 2006). It may be suspected therefore that those with
vestibular migraine are subject to an additive effect of vestibular disease and
migraine, showing particular vulnerability to symptoms of anxiety and depression.
Depression and anxiety are common psychiatric diagnoses, affecting around 13% and
10% of the UK population at one time. (King et al 2008). The standard diagnostic
criteria for these disorders are derived from DSM-IV-TR (American Psychiatric
Association 2000).
6.2 Definition of Depressive and Anxiety Symptoms
A major depressive episode is defined in DSM-IV-TR (American Psychiatric
Association 2000) as the presence of a severely depressed mood that persists for at
least two weeks (see Appendix 2 for fuller definition). This is manifest by the
experience of five or more symptoms from a list relating to low mood, anhedonia,
appetite or sleep disturbance, psychomotor agitation/retardation, low self-worth,
poor concentration and suicidal ideation.
Generalised anxiety disorder is also defined in DSM-IV-TR, within the broad and
varied family of anxiety disorders including panic disorder, agoraphobia and anxiety
disorder due to a general medical condition (American Psychiatric Association
2000). Generalised anxiety disorder (GAD) is defined as characterised by excessive,
uncontrollable and disproportionate worry (“apprehensive expectation”) for at least
six months (see Appendix 3 for fuller definition). DSM-IV specifically acknowledges
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an aspect of the relationship between vestibular disease and anxiety under the
heading “Anxiety disorder due to a general medical condition”. For this diagnosis, the
manual writes that “there must be evidence from the history, physical examination,
or laboratory findings that the disturbance is the direct physiological consequence of
a general medical condition.” To determine this, the clinician must look for a
temporal relationship between anxiety symptoms and those of the physical condition,
and features atypical of the primary anxiety disorders.
6.3 Anxiety and depression in patients with vestibular
disorders.
The relationship between vestibular symptoms and psychopathology, especially in
relation to anxiety disorders, has been well explored over the last twenty years. It has
long been recognised that the symptoms of vestibular disorders, in particular
episodic dizziness and loss of balance, are also manifest in psychological disorders
such as panic disorder and generalised anxiety disorder (Monzani et al 2001; Yardley
and Redfern 2001). This raises the issue of distinguishing the two, since the
presentations can be similar as well as present concurrently (Staab and
Ruckenstein 2003). There is less symptomatic overlap with depression, although
fatigue and lack of concentration are, in clinical practice, common complaints in
balance clinics.
The relationship is more complex however than simply making a distinction between
two separate conditions with overlapping clinical presentations. Psychological
disorders are commonly associated with vestibular disorders, and may in fact be co-
morbid. There could be pathophysiological overlap between pathways or transmitters
involved in development of anxiety or depression and the perception of dizziness.
There could be a causal relationship, for example the experience of vestibular
disorder could engender reactive depression or anxiety in predisposed individuals.
Alternatively, the persistence of dizziness symptoms may relate to pre-existing
personality or psychological factors. These ideas have been called “somatopsychic”,
where the psychological symptoms are thought of as a consequence of the physical
disorder, and “psychosomatic”, where the persistence of physical symptoms is
thought to be due to either pre-existing psychological factors, or a classical
conditioning explanation of autonomic symptoms and disorientation. Another
possibility is that psychological symptoms act as a trigger for attacks of dizziness
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through a generalised “stress” response, or vice versa, that dizziness acts as a non-
specific trigger for psychological disorder through a similar mechanism.
One study has reported that, amongst a group of 54 patients with objectively
diagnosed vestibular disorder, 50% had evidence of psychiatric disturbance when
interviewed three to five years later (Eagger, Luxon, Davies, Coelho, and Ron 1992).
This included anxiety (GAD, phobias) and depressive disorders (major depression). It
is also known that development of depressive or anxiety-based symptoms after
vestibular neuritis or other acute vestibular syndrome is associated with for poor
recovery (Best et al 2009d). BDI results have also been reported in a community
sample in Finland, showing a prevalence of 19% of mild-severe depression amongst
those who had vertiginous symptoms, twice the general population rate (Ketola et al
2007; Yardley et al 1999a). Other studies have also noted that depression can occur in
those with confirmed peripheral vestibular dysfunction (Eagger, Luxon, Davies,
Coelho, and Ron 1992; Honrubia et al 1996; Yardley et al 1992a). In a study of
patients from a balance clinic in Mexico, patients had a mean BAI score in the mild
range and a mean BDI score in the mild-moderate range (Yardley et al 1999b).
Certainly, by definition, experiencing intrusive incapacitating dizziness or vertigo is
associated with feelings of disorientation, and thereby associated with confusion,
fear, and a “precariousness of self” (Yardley L 1994). There is a sense of social
handicap, as a consequence of having a condition which is invisible to others. This
invisibility can result in a lack of empathy: “But you look fine to me.” There is some
evidence that intolerance of uncertainty is a significant factor in anxiety in Menière’s
disease (Kirby and Yardley 2009).
Lucy Yardley has written: “the links between dizziness and anxiety are complex and
bidirectional, and appear to be mediated not only by a variety of cognitive-
behavioural mechanisms, but also by multiple central connections between the
vestibular and autonomic systems” (Yardley, Medina, Jurado, Morales, Martinez, and
Villegas 1999a). For example, one factor at the neurophysiological interface between
anxiety and balance disorders is visual processing. It is reported that patients with
the least degree of retinal slip felt the most handicapped by oscillopsia, which at first
sounds paradoxical (Grunfeld et al 2000). However, the authors of this study suggest
that part of the mechanism for tolerance of oscillopsia is adaptation to retinal image
movement during self motion, more likely to occur with larger slips. Also, patients
with anxiety disorders also appear to be more visually dependent than controls in
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posturography studies (Redfern et al 2007). Other bases for the neuroanatomical
links include the strong links between the vestibular and autonomic systems (Furman
et al 1998), activation of the latter widely recognised as an intrinsic part of an acute
anxiety response. There are also distinct anatomical links between fear, anxiety,
emotion, autonomic control and vestibular information processing, via a network
centring on the parabrachial nucleus, as laid out by Balaban and Thayer (Balaban and
Thayer 2001). This schema shows the functional connections between the
parabrachial nucleus and areas which control the somatic, neuroendocrine and
visceral motor components of emotional responses, known to be associated with
anxiety and panic disorders. These areas include those which mediate autonomic
responses such as the nucleus tractus solitarius, and those which mediate fear
responses such as the central nucleus of the amygdala, the infralimbic cortex and
parts of the hypothalamus (Figure 6.1).
Figure 6.1. Scheme of central connections between balance and anxiety as devised
by Balaban and Thayer (Balaban and Thayer 2001). ((Balaban and Thayer 2001.
Copyright 2001. Reprinted with permission from Elsevier)).
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Indeed, tests of the vestibulo-ocular reflex are abnormal (unilateral caloric
hypofunction, earth vertical rotation asymmetries) more frequently in patients with
anxiety disorders than in healthy controls, although this study did not account for
confounders such as age and sex in this comparison (Jacob et al 2009). Animal
models exploring the link between balance and anxiety have been developed (Kalueff
et al 2008; Shefer et al 2010). Meniere’s disease, which is associated with episodic
vertigo, is also associated with anxiety (Kirby and Yardley 2008). However, patients
with Meniere’s disease have a constellation of difficulties distinct from other episodic
vertigo disorders, in that the condition is associated with acquired hearing loss and
also tinnitus, both of which are known of themselves to be associated with
psychological symptoms, especially anxiety and depression (Hallam et al 2006; Krog
et al 2010).
There are also pharmacological links between depression/anxiety and balance, with
noradrenergic, serotonergic and dopaminergic brainstem nuclei all having direct
connections with the vestibular nuclei. All these neurotransmitter systems are
thought to have a role in development or maintenance of depression or anxiety, and
pharmacological modification of these transmitter systems are key modes of action of
many anxiolytic or antidepressant drugs.
6.4 Anxiety and depression in patients with migraine.
As is the case for balance disorders, there are ample data showing an association
between migraine headache and both mood and anxiety disorders (Baskin et al
2006). This has been documented in a variety of ways. In population based studies,
migraineurs are more likely to suffer with depression than non-migraineurs
(Hamelsky and Lipton 2006). In one such study, carried out over two years, those
who had depression at the beginning of the study had a higher risk of developing
migraine (and not other severe headaches) over the study interval, and those who had
migraine (and not other severe headaches) at the beginning of the study had a higher
risk of developing depression (Breslau et al 2003). The simplest interpretation of
these results is that the relationship between migraine and depression is specific and
bi-directional, and may be supportive of the view that the association is due to a
common pathological mechanism, rather than a psychological consequence of
suffering unpredictable and unavoidable episodes of severe pain.
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Migraine and anxiety have also been shown to be related in population based studies,
(McWilliams et al 2004; Merikangas et al 1990). In one study general anxiety
disorder (OR 5.3, 95%CI 1.8 to 15.8) had the strongest association with migraine of
the all the anxiety disorder subtypes. This study also carried out logistic regression
analysis to determine the strength of association between psychiatric disorders
(major depression, general anxiety disorder, bipolar spectrum and social phobia) and
migraine. The best model incorporated general anxiety disorder alone (Merikangas,
Angst, and Isler 1990).
The temporal relationship documented for migraine and anxiety has not been
explored in detail, in contrast to migraine and depression. Additionally, it is less clear
that the relationship between migraine and generalised anxiety is specific to migraine
rather than being general to all types of severe headache (Hamelsky and Lipton
2006). The picture is different for data relating specifically to panic disorder where
specificity to migraine and bi-directionality are maintained (Baskin, Lipchik, and
Smitherman 2006).
There are a number of biological explanations for the relationship between migraine
and anxiety disorders. It is known that migraine and depression have a bidirectional
association at least partly explained by genetic factors (Schur et al 2009; Stam et al
2010). Also, the aminergic neurotransmitters which are modified by anxiolytic and
antidepressant drugs are present in brainstem areas such as the periaqueductal grey
thought to be important in the modulation of the trigeminovascular reflex (Holland
2009).
6.5 Migraine, vestibular disease and psychological
disorders
Given the evidence of links between migraine and psychological disorders, and
between balance and psychological disorders, it might be hypothesised that
individuals with both migraine and a balance disorder could be particularly
susceptible. Some work has been done investigating this proposition.
In one series of 100 patients with “migraine related vestibulopathy” seen in a
specialist centre, anxiety or panic disorder were reported as comorbidities in 14
(Cass, Furman, Ankerstjerne, Balaban, Yetiser, and Aydogan 1997). 53% of patients
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in one study of vestibular migraine cited stress or emotional upset as a trigger for
attacks (Brantberg, Trees, and Baloh 2005).
It is also known that migraine is a risk factor for impaired recovery after vestibular
neuritis (Best, Tschan, Eckhardt-Henn, and Dieterich 2009c). In addition, when
compared to other vestibular vertigo syndromes such as BPPV, vestibular neuritis
and Meniere’s disease, individuals with vestibular migraine are at higher risk of
developing a somatoform disorder (Best et al 2009a). However, none of the studies
which report this observation account for the variation in vertigo severity or
frequency which could conceivably account for at least some of these observed
differences.
A German population based study screening for individuals with dizziness found that
those who also had anxiety were more likely to have migraine than those who did not
have anxiety symptoms (OR 2.57 (95%CI 0.05–7.21)) (Wiltink et al 2009). This was
also true for skin and pulmonary complaints i.e. this relationship was not specific to
migraine.
In a prospective balance clinic based study, chronic (non-episodic) non vertiginous
subjective dizziness was associated with migraine in 17% cases. 47/57 of these cases
(82%) also had at least one of panic disorder, GAD, minor anxiety and major
depression (Staab and Ruckenstein 2007). This is much higher than would be
expected in the general population. The authors report that this suggests that
“anxiety related mechanisms may play a more significant role in sustaining chronic
symptoms than headache”, although perhaps this conclusion is not wholly justified
by the data, since it could just as easily be hypothesised that the headache is the cause
of the anxiety symptoms.
A recent study examining the interrelation of migraine, vestibular symptoms and
psychological disorder examined a psychiatric clinic population underwent neuro-
otological assessment (Teggi et al 2009). Migraine was equally common in those with
panic disorder without agoraphobia, those with panic disorder with agoraphobia and
those with depressive disorders. However, the panic disorder group had a higher
prevalence of migrainous vertigo as defined by Neuhauser (Neuhauser, Leopold, von
Brevern, Arnold, and Lempert 2001). In fact, almost all the patients in this study with
abnormal vestibular function on caloric testing met criteria for migrainous vertigo.
Having dizziness with migraine headaches is known to increase handicap as
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measured by MIDAS score and degree of depression (PHQ9 score) (Bisdorff et al
2010).
The links between migraine, anxiety and balance disorders have also been
synthesised as “Migraine anxiety related dizziness”, proposed as a new entity
(Furman et al 2005a). This idea is based on an amalgamation of pathophysiological
concepts relating to psychogenic and organic dizziness, and vestibular migraine. The
authors state that “MARD is unlikely to be the chance combination of a balance
disorder, migraine headache and anxiety”. They cite the high prevalence of panic
disorder in migraine, and the poorer prognosis of patients with anxiety and migraine
than migraine alone as supportive of this view. They then outline a schema for a
putative pathophysiological connection, linking the parabrachial nucleus network
with the trigeminovascular reflex via the vestibular nuclei. Although interesting in
theory, this concept has yet to be validated in clinical terms, either in diagnostics or
therapeutics.
So, it is accepted that migraine is associated with vestibular disorders, migraine is
associated with anxiety and depression, and vestibular disorders are associated with
anxiety and depression. There is also some evidence interlinking all three conditions.
It might be thus hypothesised that individuals who suffer from migraine and
vestibular disorders have a higher susceptibility to psychological symptoms than
those who suffer vestibular disorders alone. However, it is important in any such
study to control for frequency or severity of the vertigo symptoms which are
suspected to have an independent effect on the presence of psychopathology as
described above. No study has yet addressed this question specifically.
6.6 Rating Scales for Anxiety, Depression and Vertigo
What, then, would be suitable outcome measures to assess anxiety, depression and
vestibular symptom load for such a study?
Various screening instruments for GAD and depression have been developed. The
two most commonly cited depression rating scales are the Hamilton Rating Scale for
Depression (Hamilton 1960) and the Beck Depression Inventory, BDI (Beck and
Beamesderfer 1974). The BDI is a checklist of 21 items which the respondent rates on
a four point scale, scored 0 – 3, see Appendix 5. The sum is calculated to give an
overall index of the severity of depression. The BDI has well established content,
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construct and concurrent validity and correlates well with other measures of
depression (Beck et al 1988b). It was originally intended to be administered by a
clinician, but is now established as a self-report screening instrument, assessing
symptoms as reported over the past week.
The BDI, like all rating scales, has limitations. It was developed on a psychiatric
patient population, and gives considerable weight to the somatic symptoms of
depression. Relying as it does on self-report, it can be faked to suggest the responder
is depressed or otherwise (Beck and Beamesderfer 1974). Since the original version
was published, various revisions have been proposed including BDI-II (Steer et al
1998) (incorporating some text changes to the items and symptom duration record)
and BDI-PC (Steer et al 1999) (designed for use in primary care situations), but the
original BDI is still in common usage in many clinical settings and it still has an
international currency.
The Beck Anxiety Inventory was developed later than the BDI (Beck et al 1988a).
With a similar structure to the BDI, the BAI consists of 13 self report items which the
respondent rates on a four point scale scored 0-3, see Appendix 4. The BDI and BAI
have both been used to screen for psychological symptoms in patients with medical
disorders (Huffman et al 2008; Waisbren and White 2010).
There is clear overlap between symptoms of episodic vestibular disease and
symptoms of anxiety. In assessing anxiety symptoms in individuals with vestibular
disease, it is desirable to assess vertigo severity since this is one factor which is could
conceivably affect anxiety scores. A suitable measure of vertigo severity and
frequency is the Vertigo Symptom Scale, VSS, which was designed to measure vertigo
severity and distinguish it from anxiety based symptoms (Yardley et al 1992b). This
instrument has subscales to quantify autonomic sensations and arousal as distinct
from vertigo severity, and was developed in order to address some of the difficulties
with distinguishing episodic vertigo from panic disorder. 36 symptoms frequently
observed in patients with vertigo were included in a questionnaire answered by 127
vertiginous patients. The 36 symptoms were then rearranged to produce 24
questions. Later, a question on “bowel sensations’” was then removed because it
embarrassed respondents, and an item on “feeling spaced out” was omitted because it
did not discriminate well between vertigo and anxiety (Yardley, Medina, Jurado,
Morales, Martinez, and Villegas 1999a). With these changes, the final 22 questions of
VSS long form were selected, see Appendix 6.
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There are two sets of sub-scales used for grouping the responses of the VSS.
One set consists of two long scales (2 scale):
a. Vertigo severity (VER) – 19 questions
b. Somatic anxiety (or anxiety/autonomic symptom scale) (AA) - 15 questions.
The second set consists of four short sub-scales (4 scale):
a. severe vertigo(VSS-SV)/acute vertigo of vertigo scale (VACU) - 13 questions.
b. brief vertigo (VSS-BV)/vertigo of short duration (VSH) - 6 questions.
c. Autonomic symptoms (VSS-AS)/Autonomic symptom scale (AU) - 6 questions.
d. Somatisation (VSS-SOM)/ (SOM) - 5 questions.
The 4 sub-scale version was used in earlier work and now only the two long sub-
scales are recommended for use (L Yardley, personal communication). There have
also been various versions of the scale with scores from 0-4 (Yardley L et al 1994) or
0-5 (Yardley, Masson, Verschuur, Haacke, and Luxon 1992b) or 1-5 (Yardley,
Medina, Jurado, Morales, Martinez, and Villegas 1999a), making direct numerical
comparisons between studies difficult.
6.7 Hypothesis
Individuals with vestibular migraine have higher levels of depressive and anxiety-
related symptoms than other patients with other vestibular vertigo symptoms, even
when severity and frequency of vestibular symptoms are accounted for.
6.8 Methods
Unselected patients attending the Neuro-otology department with a primary
complaint of dizziness were invited to participate if they had an adequate standard of
reading and writing English to complete questionnaires. Those who gave informed
consent were required to undergo a structured physician-administered
interview/questionnaire to determine history of migraine and vestibular migraine
according to standard criteria (International Headache Society Headache
Classification Committee 2004; Neuhauser, Leopold, von Brevern, Arnold, and
Lempert 2001). All participants also completed the Vertigo Symptom Scale, Beck
Anxiety Inventory and Beck Depression Inventory (Appendices 4, 5 and 6). Where
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questionnaires were completed in the waiting area, the investigator receiving
questionnaires checked them for completeness. If items were unanswered, this was
verbally indicated to respondents who were offered another chance to complete these
unanswered items if they wished. For comparison and to validate the questionnaires,
a control sample was obtained from staff at the hospital. Potential controls were
excluded if they had a history of severe headaches, ear disease (other than infrequent
otitis media or externa) or a history of episodic dizziness.
BAI and BDI questionnaire responses were excluded from analysis if there were more
than 10% of questions either unanswered or with multiple selections for a single item
i.e. where there were three or more uninterpretable items for these 21 item
questionnaires. If patients had an index (questionnaire score) with missing data for
one or two responses, the median for the index was taken for that (those) question(s)
and added to the original total to obtain the modified total.
The items on the VSS are:
1. A feeling that things are
moving
2. Chest pains
3. Hot/cold spells
4. unsteadiness
5. nausea
6. muscle tension/soreness
7. lightheadedness
8. trembling
9. aural pressure
10. heart pounding
11. vomiting
12. limb heaviness
13. visual disturbance
14. headache
15. unable to walk or stand
without support
16. breathlessness
17. poor concentration
18. unsteadiness
19. tingling/prickling/numbness
20. low back pain
21. sweating
22. faintness
Questions 1, 7 and 18 are broken down into 5 stems based on duration of symptoms
(less than two minutes, up to 20 minutes, 20 minutes to 1 hour, several hours and
more than 12 hours).
The VSS was divided into two subscales: vertigo (questions 1,4,5,7,11 and 15, italicised
in above list) and autonomic anxiety (other questions). Data were excluded if patients
left >10% questions unanswered. For the three “stem” questions, responses were
scored zero if left unscored. (L Yardley, personal correspondence). For other
questions, the median for that subscale was used.
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The BAI items are:
1. numbness
2. feeling hot
3. wobbly legs
4. unable to relax
5. fear of the worst
6. dizziness
7. heart pounding
8. unsteadiness
9. terror
10. nervousness
11. choking feeling
12. hands trembling
13. shaking
14. fear of losing control
15. difficulty breathing
16. fear of dying
17. scared
18. indigestion
19. faint/lightheadedness
20. face flushed
21. hot/cold sweats
There is some overlap between these two scales, with VSS item 3 corresponding
closely to BAI 21, VSS 4 to BAI8, VSS 7 to BAI 6, VSS 10 to BAI 7 and VSS 16 to BAI
15 and VSS 19 to BAI 1. No anxiety is classed as 0-7; 8-15 is mild, 16-25 is moderate,
and 26-63 is severe.
The Beck indices were also calculated leaving out items which referred to symptoms
that are typical of vestibular disease (wobbliness, dizziness and unsteadiness from
BAI, health preoccupation from BDI).
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The BDI items are:
1. sadness
2. future hopelessness
3. sense of failure
4. dissatisfaction
5. sense of guilt
6. sense of being punished
7. sense of disappointment
8. self criticism
9. suicidal ideation
10. crying
11. irritability
12. interest in other people
13. making decisions
14. unattractiveness
15. work
16. sleep
17. fatigue
18. appetite
19. weight loss
20. health preoccupation
21. interest in sex
0–9 is a normal score, 10–18 suggests mild-moderate symptoms, 19–29 is regarded as
moderate-severe and 30–63 indicates severe depression. For statistical testing, the
Mann-Whitney U was used to compare means in distributions not normally distributed.
To evaluate the effect of multiple potentially significant factors, multiple linear
regression analysis was carried out, to examine the effects of gender, age, and VSS-V
scores on VSS-AA, BAI and BDI scores. Analysis was carried out using SPSS version 17.0.
6.9 Results
6.9.1. Basic descriptors and raw BAI, BDI and VSS scores
Table 6. I records the number of participant and age and sex data.
Table 6.I Participant and age and sex data
Normal
controls
Vestibular
migraine
Dizzy
controls
Significance testing
between VM and dizzy
control group
Number
recruited
51 39 44 -
F:M 34:15(67%F) 30:9 (77%F) 28:16
(67%F)
p=0.188, χ2
Age
mean±SD
37.6±11 38.2±12 46±12 p=0.004, t test
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Of the dizzy controls, 14 had a peripheral vestibular disorder confirmed on caloric testing
(including bilateral vestibular failure), 7 had a condition being managed as a peripheral
vestibular disorder although objective tests were normal, 7 had benign paroxysmal positional
vertigo, 7 had Meniere’s disease, 4 had central vestibular disorder, 1 had idiopathic
intracranial hypertension, 2 had postural hypotension and 2 had other causes of dizziness.
6.9.2 BAI and BDI scores
There were three VM patients with incomplete data for the BAI and one VM patient with
incomplete data for the BDI. One normal control was incomplete for the BDI. All dizzy
controls had complete data sets. Frequency distributions for cases and controls are shown in
figure 6.2, and noted not to conform well to the normal distribution.
Figure 6.2 BAI scores in VM patients and dizzy controls
Table 6.II shows the median BAI and BDI scores for the VM group and controls. Kruskal
Wallis testing confirms a highly significant difference between the normal controls and
patients (p=0.000) for VSS-AA and VSS-V. Since differences between normals and patients
were not the primary focus of the study, the normal controls were not subject to further
analysis.
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Table 6.II BAI and BDI scores for the VM group and controls
VM group Dizzy controls Normal
controls
BAI score total median
(IQR)
19 (10-29) 11 (6-21) 2 (0-6)
BAI without vestibular
symptoms (IQR)
13 (5-23) 5 (4-14) -
BDI score total median
(IQR)
10 (3-19) 8 (4-16) 2(0-4)
BDI without vestibular
symptoms (IQR)
9.5 (3-18) 8 (3-15) -
BAI score in normal range 7/36 (19%) 14/44 (32%) 44/51 (86%)
BAI in the mild range 8/36 (22%) 17/44 (39%) 6/51 (12%)
BAI in the moderate
range
9/36 (25%) 7/44 (16%) 1/51 (2%)
BAI in the severe range 12/36 (33%) 6/44 (14%) 0/51 (0%)
BDI in the normal range 18/38 (47%) 26/44 (59%) 46/50 (92%)
BDI in the mild-moderate
range
11/38 (29%) 14/44 (32%) 4/50 (8%)
BDI in the moderate-
severe range
9/38 (24%) 4/44 (9%) 0/50 (0%)
Using a non parametric testing (Mann Whitney U), the vestibular migraine patients have
significantly higher BAI scores (median 19) than the dizzy controls (median 11)(p=0.03).
There was no such relationship for the BDI scores (p=0.57, figure 5.3). Similar figures
applied when the BAI without vestibular symptoms (p=0.03) and BDI without vestibular
symptoms (p=0.61) were computed.
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Figure 6.3 BDI scores in VM patients and dizzy controls
On the BAI, the highest scoring item was, unsurprisingly, dizziness, followed by
unsteadiness, in both VM and dizzy control groups (Figure 6.4a). However, even when
vestibular symptom items from the BAI (items 3, 6, 8) were excluded, the VM group still had
a higher mean total than the dizzy control group (p=0.028, Mann Whitney U). For the BDI
the two groups showed similar scores across all items (Figure 6.4b).
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Figure 6.4a and b: Mean scores per item in the BAI and BDI for VM patients and
dizzy controls
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6.9.3 VSS scores
Table 5.III shows the VSS scores for VM and dizzy and normal control groups, broken down
into VSS-AA and VSS-V subscales. VSS data were incomplete on three responses in the
normal controls who were excluded.
Table 6.III VSS scores for VM and dizzy and normal control groups
VM group Dizzy controls Normal
controls
VSS-V median
(IQR)
30 (20-41) 16 (9-25) 1(0-3)
VSS-AA median
(IQR)
25 (14-36) 14 (10-22) 5 (2-13)
VSS-total median
(IQR)
58 (14-36) 30 (19-54) 6(2-16)
VSS-AA without
headache item
(IQR)
22 (11-33) 14 (9-20) -
Kruskal Wallis testing confirms a highly significant difference between the normal controls
and patients (p=0.000) for VSS-AA and VSS-V. Since differences between normals and
patients were not the primary focus of the study, the normal controls were not subject to
further analysis.
The vestibular migraine group had significantly higher scores than controls in terms of total
scores (p=0.001), and both the VSS-V (p=0.003, Mann Whitney U) and VSS-AA (p=0.002)
subscales than the dizzy controls. The difference persisted even when the headache item was
removed from VSS-AA (p=0.01). This is illustrated in Figures 6.5a and 5b.On the VSS-V
subscale, both groups scored most strongly for vertigo lasting less than two minutes, nausea,
and lightheadedness / giddiness lasting less than two minutes. On the VSS-AA subscale,
highest scoring items for the VM group were headache, ear pressure and muscle tension, and
for the dizzy controls were ear pressure, visual disturbance and loss of concentration (figures
6.6a and 6b).
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Figure 6.5a and 5b VSS scores in VM and dizzy control groups in VSS-V subscale
(top) and VSS-AA subscale (bottom)
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Figure 6.6a and 6b: VSS scores for VM patients and dizzy controls by item for
VSS-V subscale (figure 5a) and for VSS-AA subscale (figure 5b)
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6.9.4 Relationship between anxiety scales
As an internal consistency assessment, the relationship between the BAI and VSS-AA scores
was examined. As expected, there was a significant positive linear correlation between BAI
scores and VSS-AA scores (Pearson r=0.743, p=0.000, figure 6.7). This relationship was
preserved in both the VM and dizzy control groups considered separately. This correlation is
expected since both the BAI and VSS-AA scores are designed as indices of anxiety.
Figure 6.7 BAI scores against VSS-AA subscales showing correlation
6.9.5 Results by diagnostic grouping
Data were plotted according to diagnostic grouping to compare BAI, BDI, VSS-V and VSS-AA
scores across different pathologies. Distributions were broadly similar in all groups other
than vestibular migraine (figure 6.8). Kruskal Wallis one-way of analysis of variance showed
no difference in median scores between the five diagnostic groups (Table 6.IV).
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Figure 6.8. BDI (8a), BDI (8b), VSS-V (8c) and VSS-AA (8d) scores broken down
by diagnostic group. VM=vestibular migraine; Non vestib= non vestibular dizziness;
PVD CP= peripheral vestibular disorder confirmed on caloric testing; PVD no CP=
managed as peripheral vestibular disorder but normal caloric test; BPPV=benign
paroxysmal positional vertigo; central=central vestibular disorders;
Menieres=Menière’s disease.
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Table 6.IV Means and medians for BAI, BDI, VSS-AA and VSS-V across subgroups
BAI BDI VSS-AA VSS-V
Mean Med Mean Med Mean Med Mean Med
VM 21 19 12 10 25 25 31 30
nonvestibular
dizziness
21 18 7 5 29 24 26 18
PVD-CP 14 12 11 12 19 17 22 17
PVD-no CP 15 11 22 7 22 24 22 23
BPPV 15 8 13 8 16 9 12 7
central 11 6 6 5 12 10 12 11
Meniere’s 11 11 10 10 12 11 22 17
Kruskal-
Wallis p value
(Df 4)
0.660 0.710 0.316 0.496
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6.9.6 Regression modelling
Superficial inspection of data therefore suggests that the VM group has higher levels of
anxiety symptoms (BAI and VSS-AA), but may also have a higher balance symptom load. In
addition there are potential confounders in the form of age and gender. Regression analysis
was therefore carried out to deal with these variables. Since this requires normality as an
assumption, data for dependent variables were transformed using a square root function
y=x1/2 and also log (x). The transformation y= x1/2 gave better results in minimising kurtosis
and skew. Normality assumptions were then met (Table 6.V, figures 5.9a, b and c). The
transformation y=x1/2 was thus adopted for the purposes of regression, with the
nomenclature sqrt (x). In this section male gender was assigned the value 0, and female
gender was assigned the value 1.
Table 6.V Log and square root transformations
N
Minimu
m
Maximu
m Mean
Std.
Deviatio
n Skewness Kurtosis
Statistic Statistic Statistic
Std.
Error Statistic
Statisti
c
Std.
Error
Statisti
c
Std.
Error
logBAI 80 0.30 1.78 1.1468 .03708 .33168 -0.235 .269 -0.519 .532
logBDII 82 0.00 1.69 0.9184 .04930 .44645 -0.670 .266 -0.320 .526
logVSS-V 80 0.30 1.85 1.3093 .03697 .33064 -0.595 .269 -0.025 .532
logVSS-AA 80 0.30 1.71 1.2711 .03074 .27494 -0.721 .269 1.130 .532
sqrtBAI 80 1.00 7.68 3.8648 .17206 1.53892 0.446 .269 -0.449 .532
sqrtBDI 82 0.00 6.93 2.9737 .18028 1.63250 -0.028 .266 -0.303 .526
sqrtVSS-AA 80 1.00 7.07 4.3994 .15283 1.36691 0.099 .269 -0.511 .532
sqrtVSS-V 80 1.00 8.31 4.7013 .19277 1.72415 0.133 .269 -0.654 .532
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Figure 6.9. Transformed data using sqrt(x)=x1/2. The medians for sqrtBAI, sqrtVSS-
AA, sqrtBDI are 3.74, 4.42, and 3.00 respectively.
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Sqrt BAI: simple linear regression
First, age, gender, case-control (VM status vs control status) were each analysed using
simple linear regression. The results are shown in Table 6.VI. These results suggest that
vestibular migraine and VSS-V scores may be significant determinants of BAI scores.
Table 6.VI Simple linear regression for sqrt BAI
estimated
R2
Adjusted
R2
ANOVA
F value
ANOVA
p value
standardised
Beta
t
statistic
t test
p
value
Age 0 -0.13 0.000 0.997 0.000 -0.004 0.997
Gender 0.008 -0.004 0.657 0.420 0.091 0.811 0.420
case-
control
0.069 0.57 5.783 0.019 -0.263 -2.405 0.019
VSS-V 0.187 0.176 170225 0.000 0.432 0.746 0.000
Sqrt BAI: multiple linear regression
Using age, gender, case control status and VSS-V as independent variables and sqrt BAI as
the dependent variable gives the following regression equation:
sqrtBAI=0.034(VSS-V) + 0.01( age) + 0.156(gender)-0.523(casecontrol)+3.408
Standardised beta coefficient value is highest for VSS-V (0.378), compared with 0.082 for
age, 0.048 for gender and -0.173 for case-control status. R2 was 0.217 with adjusted R2 0.174.
Maximum R2 was not increased by removing regressors from the equation to form
alternative models.
The regression analysis was not a good fit, describing only 22% of the variance in sqrtBAI,
but the overall relationship was statistically significant (F=5.001, p =0.001). With other
variables held constant, sqrtBAI scores were positively correlated to age, increasing by 0.01
for every year of age, and positively related to VSS-V score, increasing the sqrtBAI by 0.034
for every unit rise in VSS-V. Women tended to have higher sqrtBAI scores than men by 0.156
points. However, the effect of VSS-V was the only significant effect (t=3.452, p=0.001).
Residual plots were satisfactory.
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The multiple linear regression analysis therefore suggests that the difference in VM when
compared to dizzy controls in terms of BAI scores can largely be attributed to VSS-V scores.
Sqrt BDI: Simple linear regression
Age, gender, case-control status and VSS-V scores were compared to sqrt BDI scores using
simple linear regression (Table 6.VII). No significant relationships were seen.
Table 6.VII Simple linear regression for sqrt BDI
estimated
R2
Adjusted
R2
ANOVA
F value
ANOVA
p value
standardised
Beta
t
statistic
t test
p
value
Age 0.006 -0.006 0.512 0.476 0.080 0.715 0.476
Gender 0.000 -0.012 0.039 0.845 0.022 0.196 0.845
case-
control
0.000 -0.012 0.010 0.921 -0.011 -0.099 0.921
VSS-V 0.035 0.023 2.815 0.097 0.188 1.678 0.097
Sqrt BDI: Multiple linear regression
Using age, gender, case control status and VSS-V as independent variables and sqrt BDI as
the dependent variable gives the following regression equation:
sqrtBDI=0.019(VSS-V) + 0.01( age) -0.043(gender)+0.097 (casecontrol)+1.908
Standardised beta coefficient value is highest for VSS-V (0.198), compared with 0.101 for
age, -0.012 for gender and 0.030 for case-control status. R2 was 0.048with adjusted R2 -
0.004.
This regression analysis was therefore a poor fit, describing only 5% of the variance in BAI,
and the overall relationship was not statistically significant (F=0.932, p=0.450), in keeping
with the preliminary finding of no relationship between BDI and these variables.
Sqrt VSS-AA:Simple linear regression
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Age, gender, case-control status and VSS-V scores were compared to sqrt VSS-AA scores
using simple linear regression (Table 6.VIII).
Table 6.VIII Simple linear regressopm for Sqrt VSS-AA
estimated
R2
Adjusted
R2
ANOVA
F value
ANOVA
p value
standardised
Beta
t
statistic
t test
p
value
Age 0.009 -0.004 0.724 0.397 0.096 0.851 0.397
Gender 0.084 0.072 7.158 0.009 0.290 2.675 0.009
casecontrol 0.100 0.089 8.703 0.004 -0.317 -2.950 0.004
VSS-V 0.508 0.258 27.173 0.000 0.508 5.213 0.000
SqrtVSS-AA: Multiple linear regression
Using age, gender, case control status and VSSV as independent variables and sqrt VSS-AA
as the dependent variable gives the following regression equation with maximum efficiency:
sqrtVSS-AA = 0.008(VSSV) + 0.398(gender)+2.938
Other models did not increase the value of R2. Standardised beta coefficient value is highest
for VSS-V (0.378), compared with 0.082 for age, 0.048 for gender and -0.173 for case-
control status. R2 was 0.217 with adjusted R2 0.174.
The regression analysis was a reasonable fit, describing 31% of the variance in VSS-AA, and
the overall relationship was statistically highly significant (F=17.544, p =0.000). With other
variables held constant, sqrt VSS-AA scores were positively related to VSS-V score,
increasing the sqrt VSS-AA by 0.039 for every unit rise in VSS-V. Women tended to have sqrt
VSS-AA higher scores than men by 0.698 points. Both VSS-V (t= 5.066, p=0.000) and
gender (t=2.476, p=0.015) effects were significant. Residual plots were satisfactory.
6.9.7. Age and anxiety nonlinearity problem
If age affects anxiety in a nonlinear way, then regression analysis will not pick up such a
relationship. Therefore, data were re-analysed with dizzy controls selected to match the age
of VM participants to within 3 years. In this sample the means for VM group were 40 yrs
with SD 11 and for the dizzy control group 40 with SD 10. This did not affect the outcome of
the regression analysis significantly.
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6.9.8. Summary of results
As expected, normal controls had significantly lower scores than both patient groups across
all measures. The vestibular migraine group had significantly higher levels of anxiety than
the dizzy control group, assessed using either the BAI or the VSS-AA. This group also had
higher levels of vertigo symptom load (VSS-V score). However, using multiple linear
regression analysis it can be seen that the significant difference in anxiety scores between the
groups in terms of BAI scores disappears when the difference in VSS-V scores is taken into
account. Similarly, multiple linear regression analysis suggests that the differences in VSS-
AA scores between VM cases and controls are largely accounted for by differences in VSS-V
and in gender. There was no significant difference between the groups in terms of BDI score.
6.10 Discussion
These data show a burden of psychological symptomatology carried by patients recruited
from a specialist neuro-otology clinic with vestibular migraine and with other forms of
dizziness, but especially with the former. Both groups had significantly worse scores than
normal controls. A third of the patients with VM scored in the severe range on the BAI, as
did 14% of the control group of dizzy patients. This is in keeping with previous reports that
vestibular disorders, and migraine, are both potentially associated with psychopathology.
This sample, taken from a tertiary neuro-otology clinic, is likely to represent the severe end
of the spectrum of disease. It is interesting to note that the VM group have significantly
higher BAI scores than the dizzy control group, even when items which correspond directly
to typical vestibular symptoms are excluded. Similarly, they score more highly on the VSS-V
and VSS-AA subscales. Unsurprisingly, the VM group are more troubled by headache than
the other dizzy controls.
The picture is however, more complex than this superficial initial inspection of the data
would suggest. The VM group scored more highly on the VSS-V, and there is a correlation
between VSS-V and BAI scores, could the difference in anxiety scores be accounted for by a
difference in vertigo symptom load? Also, could there be any effect of confounders such as
age and gender?
Regression analysis confirms that this is so. The interaction of gender and VSS-V scores
renders case-control status insignificant as a predictor of VSS-AA scores. For the other index
of anxiety used in this study, the BAI, VSS-V is the only significant factor.
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One possible explanation for the difference in anxiety scores in the raw data is the difference
in age distribution between the two groups. A previous study which examined psychiatric
symptoms in different vestibular syndromes found no effect of age (Eckhardt-Henn et al
2008). On the other hand, it is known from primary care based studies that anxiety
prevalence is highest in women aged 20-29, and declines at older ages (Martin-Merino et al
2010). It is possible that at least some of the high anxiety levels reported elsewhere are
related to the age and sex distribution of VM. One large population based epidemiological
study showed a median age of onset of 23 years with 82% female preponderance (Lempert
and Neuhauser 2009). However, in the regression model, age is not significant as a predictor
of either VSS-AA or BAI. This model cannot however account for a nonlinear relationship
with age, which might occur if anxiety symptoms peak in early adult life. For this reason, the
data were re-analysed using individuals selected from the larger sample to match for age.
The outcomes were essentially unchanged. This suggests that the increased anxiety symptom
load seen in the VM sample may be largely due to a higher vertigo symptom load.
Are the observed effects the result of the design of the rating scales selected? It was noted
earlier that the rating scales for anxiety and depression all contain items which would be
expected to score highly in individuals with physical disorders of balance and headache.
Indeed, headache is the item scored most highly by the VM group on the VSS-AA subscale.
However, even when vestibular symptom items from the BAI (items 3, 6, 8) were excluded,
the VM group still had a higher mean total than the dizzy control group (p=0.028, Mann
Whitney U). The same applies to the VSS-AA scores when headache is excluded. This
suggests that the scores and analyses have not been excessively influenced by these items.
Depression scores were similar in the two groups. Both groups had a high proportion of
individuals scoring outside the normal range. Migraine is known to be associated with
depressive symptoms, and there is evidence suggesting that those with vestibular symptoms
may also be more susceptible. This study however found no evidence in support of a
synergistic or additive effect of the two disorders on depressive symptom scores, since the
levels were similar in the VM and dizzy control groups.
Why do the VM patients appear to have more severe vertigo, and, associated higher anxiety
levels? One possibility is that this is a chance consequence of sampling. Another possibility is
that patients with VM are referred to the clinic later at a later stage in the condition, perhaps
due to the under-recognition of the condition previously reported elsewhere (Neuhauser,
Radtke, von Brevern, Feldmann, Lezius, Ziese, and Lempert 2006). One might also speculate
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that VM patients could have a higher tendency to report symptoms, i.e. a higher degree of
somatic focus, perhaps, as a result of contending with a headache disorder as well as a
vestibular disorder. These data do not answer these questions, and further research could
address these issues. It is known from other work that patients with migraine and dizziness
achieve worse scores across a range of mental and physical health and quality of life
measures (Bisdorff, Andree, Vaillant, and Sandor 2010). Since migraine is known to be an
adverse prognostic factor for recover in some vestibular syndromes (Best, Tschan, Eckhardt-
Henn, and Dieterich 2009c), perhaps due to impeded central compensation, there may be a
physiological explanation why migraineurs appear to have more severe symptoms.
However, other reports do suggest that individuals with VM do have a more “severe”
presentation, as discussed above. For example, those with vestibular migraine are known to
have a higher risk of developing somatoform dizziness (Best, Eckhardt-Henn, Tschan, and
Dieterich 2009a). This same study reported on the other hand that there was no correlation
with the degree of vestibular dysfunction as measured by objective neuro-otological
assessment including caloric test, ocular torsion and subjective visual vertical measures.
However, it is recognised that none of these objective measures has been shown to correlate
with the experience of vertigo or reported symptom severity, so these observations do not
negate the idea that VM individuals may experience symptoms more severely. This notion is
also in keeping with concepts of migraine in general as a disorder of heightened sensitivity to
sensory stimuli. Vestibular symptoms such as head and visual motion intolerance may have
much lower thresholds in such predisposed individuals.
Other studies have reported a difference in the prevalence of psychiatric disorder between
different vestibular disorders, with VM scoring more highly than other conditions such as
BPPV. To some extent this is replicated in this study since we do find that the vestibular
migraine group have significantly more anxiety than other groups.
It must be remembered when interpreting these data that, given the sample source in a
tertiary Neuro-otology clinic, the degree to which these observations generalise to other
populations may be limited. Also, the scales used are merely screening instruments which
can give an approximate indication of severity of symptoms, but should not be confused with
a formal psychiatric diagnosis which can only be made by interview.
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6.11 Conclusions
In this tertiary level specialist clinic population, patients with vestibular migraine have
higher anxiety scores than patients with dizziness due to other conditions. This appears to be
largely accounted for by the higher levels of vertigo severity reported by this group. Whatever
the underlying explanation, individuals with VM seen in a clinic setting can be regarded as at
high risk for developing symptoms of anxiety, and clinicians should be aware of this.
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Chapter 7. Overall conclusions
7.1 Aim and initial hypotheses revisited
The work presented in this thesis has examined audiovestibular sensory processing
in migraine using varied and complementary techniques, and made novel
observations contributing to the understanding of sensory processing in migraine.
The original hypothesis for this study was that migraine in general, and vestibular
migraine (VM) in particular, are characterised by abnormalities in audiovestibular
processing in the brainstem. Sensory processing via the brainstem in individuals
with VM was examined using the recently developed translational techniques of
vestibular evoked myogenic potentials and otoacoustic emission recordings including
suppression by contralateral noise.
As well as examining interictal processing of audiovestibular stimuli, the study
considered the hypothesis that such stimuli could act as triggers for an attack of
migraine, since in the past this had been noted in a small number of individuals and
this observation required further systematic evaluation. This is another dimension of
sensory processing in migraine, the capacity of stimuli to cause an individual to reach
the threshold at which attacks occur.
In addition it was hypothesised that the recognised psychological effects associated
with vestibular migraine are due to a synergistic effect between the migraine and
vestibular symptoms, so that those with vestibular migraine experience greater
psychological symptom load than non-migrainous dizzy controls. Studies were
constructed to examine each of these hypotheses in turn, and each has been
systematically addressed in the preceding chapters.
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7.2 Summary of principal findings
 The use of vestibular stimulation appeared to act as a migraine trigger in a
high proportion (49%) of individuals with a history of migraine when
compared with 5% of a control population (p=0.001).
 Otoacoustic emission study using contralateral suppression in patients with
VM showed that a higher than expected proportion of subjects with vestibular
migraine have low total OAE suppression (11/33 cases vs 3/31 controls,
p=0.02).
 There is a high rate of absence of responses amongst those with vestibular
migraine (5/35), a finding conspicuous by its absence (0/30) amongst the
healthy control population (p=0.06). There is a higher overall rate of all
abnormalities amongst the VM population than the controls (p=0.036).
 Individuals with vestibular migraine have a high rate of psychological
symptom load (median BAI score 19) suggestive of anxiety disorder, when
compared to dizzy controls without a history of migraine (median BAI score
11, p=0.3).
 The rates of depressive symptoms are similar in patients with VM and dizzy
controls (median BDI scores 10 and 8 respectively, p=0.57).
 Multiple logistic regression modelling showed that the difference in
psychological symptom burden was largely explicable by the much higher
vestibular symptom load carried by these patients.
7.3 Summary of secondary findings
 There was no demonstrable relationship between the subjective experience of
phonophobia and reduced OAE suppression, with phonophobia present in
91% cases of low suppression and 86% cases of normal suppression. In a
focussed study, there was higher variability in suppression during attacks of
vestibular migraine in two out of three individuals.
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 Similarly, there was higher variability in VEMP recordings, with large latency
shifts unilaterally in two individuals, one becoming shorter in the interictal
condition and one becoming longer.
 When migraines were triggered by vestibular stimuli, the resulting migraine
attack involved vestibular symptoms in only 46% cases.
7.4 General interpretation of findings
This work has outlined disruption in auditory efferent function in a group of
individuals. The defining characteristics of this group are yet to be elucidated. The
objective phenomenon of OAE suppression by contralateral noise did not, however,
relate to the subjective experience of phonophobia. However, since 88% of VM
patients had phonophobia, there was limited power to detect such an effect. The
VEMP study parallels previous work using objective vestibular tests in migraine, in
that the findings show great heterogeneity that can only partly be explained by
technical differences.
It is interesting to compare the results obtained in the VEMP and OAE suppression
mechanism parts of this thesis. The types of abnormality documented vary, as would
be expected given that these two techniques are quite different. One clear parallel,
however, is the ictal and interictal comparisons made. Using both techniques, the key
observation was of excessive magnitude of change between the two recording
conditions, with variable direction of change. One might speculate that this is a
characteristic of the migraineur’s state, that normal mechanisms of sensory gain
modulation are impaired in a variable way. Against this notion it could be argued
that the migraineur in the ictal state is always more responsive than in the interictal
state: the threshold for response does not increase during an attack. Patients do not
report feeling less sensitive to sound or light during attacks. Still, as observed in the
otoacoustic emission suppression study, a simple relationship between perceived
experience and reported symptoms, and the objective physiological measures is often
elusive. Since the numbers of ictal-interictal comparisons made were small, it is
important not to place excessive weight on these observations, but it is interesting
that the VEMP and OAE suppression data give a similar picture in this respect.
The work on induced vertigo as migraine triggers suggests a new concept of primary
and secondary vestibular migraine. In primary vestibular migraine the vestibular
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symptoms arise directly from the migraine itself, and in secondary vestibular
migraine, the vestibular symptoms arise secondary to an alternative aetiology which
is provoking migraine headache. This notion could contribute to refinement of the
concept of vestibular migraine, and account for some of the observed clinical
heterogeneity of the condition, especially in terms of vestibular test findings
(discussed in Introduction, section 1.3). The findings of the VEMP and OAE
suppression work contained in this thesis emphasise this heterogeneity. The findings
presented in this thesis show that neither of these two techniques will be sensitive or
specific enough to be of diagnostic utility for VM.
While definitions are dependent on clinical description, and while there continues to
be phenotypic overlap with other vestibular disorders such as Menière’s disease, this
is likely to remain the case. Much has advanced since Neuhauser et al published their
landmark paper nearly 10 years ago (Neuhauser, Leopold, von Brevern, Arnold, and
Lempert 2001). Revision of diagnostic criteria is underway among the international
balance disorders community, starting with standardised definitions of vestibular
symptom terms, (Bisdorff et al 2009) and the search for an improved definition to
aid clinicians, researchers and sufferers continues.
7.5 Limitations of study
The study was set in the neurology and neuro-otology departments of a tertiary level
specialist hospital and the findings presented may have limited generalisability
outside this setting. This is especially relevant in the interpretation of the
psychological symptoms, since the patient population seen in this setting is likely to
be biased towards more severe cases of VM. There were methodological limitation
associated with each subsection of the study and discussed in the relevant chapters
(3, 4, 5 and 6).
7.6 Future directions – where next?
The work highlights the need for a systematic study of phonophobia and heightened
auditory sensitivity in migraine attacks. A validated instrument would be of use,
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since patients vary considerably in their responses to questions about phonophobia
(Evans, Seifert, Kailasam, and Mathew 2008). It would also potentially be of interest
to consider the phenomenon of phonophobia during migraine attacks in groups with
specific auditory deficits, such as profound hearing loss, low and high frequency loss,
auditory neuropathy and central auditory processing disorders. Patients with
profound hearing losses could conceivably experience phonophobia in the form of
exacerbation of headache by sound, as long as they have some means of sound
detection. This could be through the high sound intensities that profoundly deaf
patients may still perceive, or via vestibular detection of sound (cf the observation
that profoundly deaf patients show VEMP responses to sound stimuli (Welgampola
and Colebatch 2005)).
Technical advances in VEMP techniques (e.g. ocular VEMP recordings, assessment
of habituation) may yield further understanding of the pathways affected in migraine
in general and VM in particular, although on the basis of the literature so far seems
unlikely to provide the definitive answer to the elusive question of the
pathophysiological mechanism of vestibular migraine.
At least in the study setting, individuals with vestibular migraine are greatly
burdened by their condition. The question of why this patient group is so much more
disabled than others is relevant. Is vestibular migraine an intrinsically more
disabling condition than other vestibular disorders commonly seen in a balance
clinic? Are those with vestibular migraine referred late for specialist help? Is the
management of this disorder more complex than for other conditions?
In conclusion, this work contributes to the body of knowledge on migraine in general
and vestibular migraine in particular, and suggests plentiful further fruitful lines of
enquiry to understand this important problem.
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Appendix 1 Vestibular migraine anamnesis
1) Are you or have you been subject to headaches?
No Yes
If ‘No’ please answer the questions 14b to 17 of the questionnaire.
2) Do your headaches come in more or less identical attacks?
No Yes
3) Are your headaches
A. at the front ?………………………….No Yes
B. on both sides of your head ?……….No Yes
C. at the back of your head ?………….No Yes
D. In your neck?....................................No Yes
4) How old were you when your headache started? (in years) ----------
5) When was your last headache?
A. 0-7 days ago
B. 1 week to 4 weeks ago
C. 1 month to 6 months ago
6) How long does your headache last on average?
A. 1 to 60 minutes
B. 1 to 2 hours
C. 2 to 24 hours
D. 1 to 7 days
E. longer than 1 week
7) How often do you get headaches?
A. several times a day
B. daily
C. once or twice a week
D. once or twice a month
E. several times a year
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F. once every few years
G. in association with menstrual cycle
8) Do your headaches have a throb at any time during the attack?
No Yes
9) How severe is your headache?
A. Mild
B. Moderate
C. Severe (interferes with daily activity)
10) When was the last time you had a typical headache?
-------------------- (hours / days / months ago)
11) Do you have dizzy spells at other times than with your headaches?
No Yes
If No, go to question 12.
11a) Do the dizzy spells occur more than once between spells of headache?
No Yes
11b) How long do these dizzy spells last?
A. Few seconds
B. 1 to 60 minutes
C. 1 to 24 hours
D. 1 to 7 days
E. longer than 1 week
11c) Are your dizzy spells related to head movements?
No Yes
12) Are your headaches relieved by any of the following?
a. Aspirin No Yes
b. Cafergot No Yes
c. Migraleve No Yes
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d. Neurofen / ibuprofen No Yes
e. Coproxamol No Yes
f. Cocodamol No Yes
g. Imigran No Yes
h. maxalt No Yes
i. migraine prophylaxis (preventives) No Yes
eg propranolol, pizotifen, amitryptiline
(specify name ……………………………………….…)
j. other medicine No Yes
(specify name ……………………………………….…)
13) Have you ever had motion sickness? No Yes
If no, go to question 14.
13a) If ‘Yes’
A. during childhood only
B. in childhood and adulthood
C. adult only
13b.) If you ever had motion sickness does it occur when travelling by
A. car? No Yes
B. bus? No Yes
C .train? No Yes
14a) During or within an hour before your attack of headache, do you have any of the
following complaints? If Yes, please circle to show whether it is before or during the attack,
for each of the choices given.
a) spots/shimmering lights/ zigzag lights in your field of vision?
No Yes (before /during)
b) Dark areas at the centre of your vision?
No Yes (before /during)
c) Darkness in one half of your vision?
No Yes (before / during)
d) Numbness or tingling around your mouth?
No Yes (before / during)
e) Numbness or tingling over one half of your face or body?
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No Yes (before / during)
f) Weakness on one side /both sides of your face or body?
No Yes (before / during)
g) Difficulty with finding the right words or understanding words?
No Yes (before / during)
h) Dizziness No Yes (before / during)
i) Unsteadiness No Yes (before / during)
j) Double vision No Yes (before / during)
k) Slurred speech No Yes (before / during)
l) Noises in your ear/s No Yes (before / during)
m) Hearing loss No Yes (before /during)
n) Decreased level of consciousness No Yes (before / during)
o) Blackouts No Yes (before / during)
14b) During or within an hour before your attack of vertigo or dizziness, do you have any of
the following complaints? If Yes, please circle to show whether it is before or during the
attack, for each of the choices given.
a) spots/shimmering lights/ zigzag lights in your field of vision?
No Yes (before /during)
b) Dark areas at the centre of your vision?
No Yes (before /during)
c) Darkness in one half of your vision?
No Yes (before / during)
d) Numbness or tingling around your mouth?
No Yes (before / during)
e) Numbness or tingling over one half of your face or body?
No Yes (before / during)
f) Weakness on one side /both sides of your face or body?
No Yes (before / during)
g) Difficulty with finding the right words or understanding words?
No Yes (before / during)
h) Dizziness No Yes (before / during)
i) Unsteadiness No Yes (before / during)
j) Double vision No Yes (before / during)
k) Slurred speech No Yes (before / during)
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l) Noises in your ear/s No Yes (before / during)
m) Hearing loss No Yes (before /during)
n) Decreased level of consciousness No Yes (before / during)
o) Blackouts No Yes (before / during)
15) Do you have any of the following complaints during your attacks
(headaches/vertigo/dizziness)?
a. Nausea No Yes
b. Nausea and vomiting No Yes
c. Increased sensitivity to bright lights No Yes
d. Increased sensitivity to loud sounds No Yes
e. Disturbance by smells No Yes
f. Nervousness and irritability No Yes
g. Aggravated by walking stairs or similar routine physical activities
No Yes
16) Are your dizzy spells accompanied by noise in your ears or change in your hearing?
No Yes
17) Have any of your relatives complained of headaches or have they been diagnosed as
having migraine/or
have attack like the ones you have? No Yes
(if yes who?
E.g. brother / mother .........................................................................................................)
Thank you for filling in the questionnaire
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Appendix 2 Diagnostic criteria for major depressive episode in DSM-IV TR
A. Five (or more) of the following symptoms have been present during the same 2-
week period and represent a change from previous functioning; at least one of the
symptoms is either (1) depressed mood or (2) loss of interest or pleasure.
Note: Do not include symptoms that are clearly due to a general medical
condition, or mood-incongruent delusions or hallucinations.
(1) depressed mood most of the day, nearly every day, as indicated by either
subjective report (e.g., feels sad or empty) or observation made by others (e.g.,
appears tearful).
(2) markedly diminished interest or pleasure in all, or almost all, activities most of
the day, nearly every day (as indicated by either subjective account or observation
made by others)
(3) significant weight loss when not dieting or weight gain (e.g., a change of more
than 5% of body weight in a month), or decrease or increase in appetite nearly every
day.
(4) insomnia or hypersomnia nearly every day
(5) psychomotor agitation or retardation nearly every day (observable by others, not
merely subjective feelings of restlessness or being slowed down)
(6) fatigue or loss of energy nearly every day
(7) feelings of worthlessness or excessive or inappropriate guilt (which may be
delusional) nearly every day (not merely self-reproach or guilt about being sick)
(8) diminished ability to think or concentrate, or indecisiveness, nearly every day
(either by subjective account or as observed by others)
(9) recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation
without a specific plan, or a suicide attempt or a specific plan for committing suicide
B. The symptoms do not meet criteria for a Mixed Episode.
C. The symptoms cause clinically significant distress or impairment in social,
occupational, or other important areas of functioning.
D. The symptoms are not due to the direct physiological effects of a substance (e.g., a
drug of abuse, a medication) or a general medical condition (e.g., hypothyroidism).
E. The symptoms are not better accounted for by bereavement, i.e., after the loss of a
loved one, the symptoms persist for longer than 2 months or are characterized by
marked functional impairment, morbid preoccupation with worthlessness, suicidal
ideation, psychotic symptoms, or psychomotor retardation.
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Appendix 3 Diagnostic criteria for generalised anxiety disorder in DSM-IV TR
A. Excessive anxiety and worry (apprehensive expectation), occurring more days than not for
at least 6 months, about a number of events or activities (such as work or school
performance).
B. The person finds it difficult to control the worry.
C. The anxiety and worry are associated with three (or more) of the following six symptoms
(with at least some symptoms present for more days than not for the past 6 months).
(1) restlessness or feeling keyed up or on edge
(2) being easily fatigued
(3) difficulty concentrating or mind going blank
(4) irritability
(5) muscle tension
(6) sleep disturbance (difficulty falling or staying asleep, or restless unsatisfying sleep)
D. The focus of the anxiety and worry is not confined to features of an
Axis I disorder, e.g., the anxiety or worry is not about having a Panic
Attack (as in Panic Disorder), being embarrassed in public (as in Social
Phobia), being contaminated (as in Obsessive-Compulsive Disorder),
being away from home or close relatives (as in Separation Anxiety
Disorder), gaining weight (as in Anorexia Nervosa), having multiple
physical complaints (as in Somatization Disorder), or having a serious
illness (as in Hypochondriasis), and the anxiety and worry do not occur
exclusively during Posttraumatic Stress Disorder.
E. The anxiety, worry, or physical symptoms cause clinically significant
distress or impairment in social, occupational, or other important areas
of functioning.
F. The disturbance is not due to the direct physiological effects of a
substance (e.g., a drug of abuse, a medication) or a general medical
condition (e.g., hyperthyroidism) and does not occur exclusively during
a Mood Disorder, a Psychotic Disorder, or a Pervasive Developmental
Disorder.
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Appendix 4 The Beck Anxiety Inventory
Below is a list of common symptoms of anxiety. Please carefully read each item in the list.
Indicate how much you have been bothered by that symptom during the past month,
including today, by circling the number in the corresponding space in the column next to
each symptom.
Not At All Mildly but it
didn’t bother
me much.
Moderately - it
wasn’t pleasant at
times
Severely – it
bothered me a
lot
Numbness or
tingling
0 1 2 3
Feeling hot 0 1 2 3
Wobbliness in legs 0 1 2 3
Unable to relax 0 1 2 3
Fear of worst
happening
0 1 2 3
Dizzy or
lightheaded
0 1 2 3
Heart
pounding/racing
0 1 2 3
Unsteady 0 1 2 3
Terrified or afraid 0 1 2 3
Nervous 0 1 2 3
Feeling of choking 0 1 2 3
Hands trembling 0 1 2 3
Shaky / unsteady 0 1 2 3
Fear of losing
control
0 1 2 3
Difficulty in
breathing
0 1 2 3
Fear of dying 0 1 2 3
Scared 0 1 2 3
Indigestion 0 1 2 3
Faint /
lightheaded
0 1 2 3
Face flushed 0 1 2 3
Hot/cold sweats 0 1 2 3
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Appendix 5 The Beck Depression Inventory
On this questionnaire are groups of statements. Please read each group of statements carefully, then
pick out the one statement in each group which best describes the way you have been feeling in the
past week including today.
1. 0 I do not feel sad.
1 I feel sad
2 I am sad all the time and I can't snap out of it.
3 I am so sad and unhappy that I can't stand it.
2.
0 I am not particularly discouraged about the future.
1 I feel discouraged about the future.
2 I feel I have nothing to look forward to.
3 I feel the future is hopeless and that things cannot improve.
3.
0 I do not feel like a failure.
1 I feel I have failed more than the average person.
2 As I look back on my life, all I can see is a lot of failures.
3 I feel I am a complete failure as a person.
4.
0 I get as much satisfaction out of things as I used to.
1 I don't enjoy things the way I used to.
2 I don't get real satisfaction out of anything anymore.
3 I am dissatisfied or bored with everything.
5.
0 I don't feel particularly guilty
1 I feel guilty a good part of the time.
2 I feel quite guilty most of the time.
3 I feel guilty all of the time.
6.
0 I don't feel I am being punished.
1 I feel I may be punished.
2 I expect to be punished.
3 I feel I am being punished.
7.
0 I don't feel disappointed in myself.
1 I am disappointed in myself.
2 I am disgusted with myself.
3 I hate myself.
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8.
0 I don't feel I am any worse than anybody else.
1 I am critical of myself for my weaknesses or mistakes.
2 I blame myself all the time for my faults.
3 I blame myself for everything bad that happens.
9.
0 I don't have any thoughts of killing myself.
1 I have thoughts of killing myself, but I would not carry them out.
2 I would like to kill myself.
3 I would kill myself if I had the chance.
10.
0 I don't cry any more than usual.
1 I cry more now than I used to.
2 I cry all the time now.
3 I used to be able to cry, but now I can't cry even though I want to.
11.
0 I am no more irritated by things than I ever was.
1 I am slightly more irritated now than usual.
2 I am quite annoyed or irritated a good deal of the time.
3 I feel irritated all the time.
12.
0 I have not lost interest in other people.
1 I am less interested in other people than I used to be.
2 I have lost most of my interest in other people.
3 I have lost all of my interest in other people.
13.
0 I make decisions about as well as I ever could.
1 I put off making decisions more than I used to.
2 I have greater difficulty in making decisions more than I used to.
3 I can't make decisions at all anymore.
14.
0 I don't feel that I look any worse than I used to.
1 I am worried that I am looking old or unattractive.
2 I feel that there are permanent changes in my appearance that make me look unattractive.
3 I believe that I look ugly.
15.
0 I can work about as well as before.
1 It takes an extra effort to get started at doing something.
2 I have to push myself very hard to do anything.
3 I can't do any work at all.
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16.
0 I can sleep as well as usual.
1 I don't sleep as well as I used to.
2 I wake up 1-2 hours earlier than usual and find it hard to get back to sleep.
3 I wake up several hours earlier than I used to and cannot get back to sleep.
17.
0 I don't get more tired than usual.
1 I get tired more easily than I used to.
2 I get tired from doing almost anything.
3 I am too tired to do anything.
18.
0 My appetite is no worse than usual.
1 My appetite is not as good as it used to be.
2 My appetite is much worse now.
3 I have no appetite at all anymore.
19.
0 I haven't lost much weight, if any, lately.
1 I have lost more than five pounds.
2 I have lost more than ten pounds.
3 I have lost more than fifteen pounds.
20.
0 I am no more worried about my health than usual.
1 I am worried about physical problems such as aches and pains, or upset stomach, or
constipation.
2 I am very worried about physical problems and it's hard to think of much else.
3 I am so worried about my physical problems that I cannot think about anything else.
21.
0 I have not noticed any recent change in my interest in sex.
1 I am less interested in sex than I used to be.
2 I have almost no interest in sex.
3 I have lost interest in sex completely.
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Appendix 6 The Vertigo Symptom Scale
The following questions ask about the type of symptoms you experience and how many times you
have experienced each of the symptoms listed below during the past 12 months (or since the
vertigo started, if you have had vertigo for less than one year).
The meanings of the numbered responses are:
0 1 2 3 4
Never A few
times
(1-3 times
a year)
Several
times
(4-12 times
a year)
Quite often (on average,
more than once a month)
Very often (on average,
more than once a week)
How often do you have the following symptoms:
1. A feeling that things are spinning or moving around, lasting:(please answer all the categories)
a) Less than two minutes 0 1 2 3 4
b) Up to 20 minutes 0 1 2 3 4
c) 20 minutes to 1 hour 0 1 2 3 4
d) Several hours 0 1 2 3 4
e) More than 12 hours 0 1 2 3 4
2. Pains in the heart or chest region 0 1 2 3 4
3. Hot or cold spells 0 1 2 3 4
4. Unsteadiness so severe that you
actually fall 0 1 2 3 4
5. Nausea ( feeling sick), stomach
churning 0 1 2 3 4
6. Tension/soreness in your muscles 0 1 2 3 4
7. A feeling of being light-headed,
”swimmy” or giddy, lasting :( please answer all the categories)
a) Less than two minutes 0 1 2 3 4
b) Up to 20 minutes 0 1 2 3 4
c) 20 minutes to 1 hour 0 1 2 3 4
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d) Several hours 0 1 2 3 4
e) More than 12 hours 0 1 2 3 4
8. Trembling, shivering 0 1 2 3 4
9. Feeling of pressure in the ear(s) 0 1 2 3 4
10. Heart pounding or fluttering 0 1 2 3 4
11. Vomiting 0 1 2 3 4
12. Heavy feeling in arms or legs 0 1 2 3 4
13. Visual disturbances (e.g. blurring
spots before the eyes) 0 1 2 3 4
14. Headache or feeling of pressure
in the head 0 1 2 3 4
15. Unable to walk or stand properly
without support 0 1 2 3 4
16. Difficulty breathing, short of breath 0 1 2 3 4
17. Loss of concentration or memory 0 1 2 3 4
18. Feeling unsteady about to lose balance,
lasting: (PLEASE ANSWER ALL THE CATEGORIES)
a) Less than two minutes 0 1 2 3 4
b) Up to 20 minutes 0 1 2 3 4
c) 20 minutes to 1 hour 0 1 2 3 4
d) Several hours 0 1 2 3 4
e) More than 12 hours 0 1 2 3 4
19. Tingling, prickling or numbness
in parts of the body 0 1 2 3 4
20. Pains in the lower part of your
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back 0 1 2 3 4
21. Excessive sweating 0 1 2 3 4
22. Feeling faint, about to black out 0 1 2 3 4
Thank you for filling in the questionnaire.
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Abbreviations
5-HT 5 hydroxytryptamine
ABR auditory brainstem reponse
BAI Beck anxiety inventory
BDI Beck depression inventory
BPPV benign paroxysmal positional vertigo
CGRP calcitonin gene related peptide
CSD cortical spreading depression
EMG eectromyography
ENG electronystagmography
FHM familial hemiplegic migraine
GABA gamma amino butyric acid
GAD generalised anxiety disorder
ICC intraclass correlation coefficient
ICHD-II International Classification of Headache Disorders
IHS International Headache Society
LOC lateral olivocochlear
MOC medial olivocochlear
MRI magnetic resonance imaging
NAR normalized amplitude ratio
OAE(q/n) otoacoustic emission (in quiet/noise)
SD standard deviation
SL sensation level
SPL sound pressure level
TEOAE transient evoked otoacoustic emission
Ts total suppression
VEMP vestibular evoked myogenic potential
VM/MV vestibular migraine/migrainous vertigo
VSS-AA vertigo symptom scale-autonomic anxiety
VSS-V vertigo symptom scale-vertigo severity/frequency
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